ESPEN guidelines on nutrition in cancer patients

Clinical Nutrition

Volumn 36, Issue 1, 2017, Pages 11-48

  Arends, Jann ^a   Bachmann, Patrick ^b   Baracos, Vickie ^c   Barthelemy, Nicole ^d   Bertz, Hartmut ^a   Bozzetti, Federico ^e   Fearon, Ken ^f   Hütterer, Elisabeth ^g   Isenring, Elizabeth ^h   Kaasa, Stein ⁱ   Krznaric, Zeljko ^j   Laird, Barry ^k   Larsson, Maria ^l   Laviano, Alessandro ^m   Mühlebach, Stefan ⁿ   Muscaritoli, Maurizio ^m   Oldervoll, Line ^i,o   Ravasco, Paula ^p   Solheim, Tora ^q,r   Strasser, Florian ^s   de van der Schueren, Marian ^t,u   Preiser, Jean Charles ^v   more..

^a UNIVERSITY OF FREIBURG   (Germany)

^b CENTRE LÉON BÉRARD   (France)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e UNIVERSITY OF MILAN   (Italy)

^f WESTERN GENERAL HOSPITAL   (United Kingdom)

^g MEDICAL UNIVERSITY OF VIENNA   (Austria)

^h BOND UNIVERSITY   (Australia)

ⁱ NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^j UNIVERSITY OF ZAGREB   (Croatia)

^k BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^l KARLSTAD UNIVERSITY   (Sweden)

^m SAPIENZA UNIVERSITY OF ROME   (Italy)

ⁿ UNIVERSITY OF BASEL   (Switzerland)

^o Norwegian Association of Heart and Lung Patients (LHL)   (Norway)

^p INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^q NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^r TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^s CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^t VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^u HAN UNIVERSITY OF APPLIED SCIENCES   (Netherlands)

^v ERASME HOSPITAL   (Belgium)

more..

Author keywords

Anorexia; Cachexia; Cancer; Chemotherapy; Exercise training; Guideline; Hematopoietic stem cell transplantation; Malnutrition; Nutrition assessment; Nutrition therapy; Palliative care; Radiotherapy; Sarcopenia; Surgery

Indexed keywords

ADVANCED CANCER; ARTICLE; CANCER PATIENT; CANCER SURVIVOR; CATABOLISM; CLINICAL OUTCOME; COMPARATIVE STUDY; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; EXERCISE; FOOD INTAKE; HUMAN; MALNUTRITION; MEDICAL EXPERT; META ANALYSIS (TOPIC); METABOLIC DISORDER; MUSCLE MASS; NUTRITION; NUTRITIONAL ASSESSMENT; NUTRITIONAL REQUIREMENT; PARENTERAL NUTRITION; PATIENT COUNSELING; PATIENT MONITORING; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPONSIBILITY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCREENING TEST; SYSTEMATIC REVIEW (TOPIC); TERMINAL CARE; DIET; HEALTH CARE ORGANIZATION; NEOPLASM; NUTRITION POLICY; NUTRITIONAL STATUS; OBSERVATIONAL STUDY;

DIET; EVIDENCE-BASED MEDICINE; EXERCISE; HUMANS; META-ANALYSIS AS TOPIC; NEOPLASMS; NUTRITION ASSESSMENT; NUTRITION POLICY; NUTRITIONAL REQUIREMENTS; NUTRITIONAL STATUS; OBSERVATIONAL STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOCIETIES, SCIENTIFIC;

EID: 84994804546     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2016.07.015     Document Type: Article

References (475)

1. Preiser, J.C., Schneider, S.M., ESPEN disease-specific guideline framework. Clin Nutr 30 (2011), 549–552.
2. Andreyev, H.J., Norman, A.R., Oates, J., Cunningham, D., Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?. Eur J Cancer 34 (1998), 503–509.
3. Pressoir, M., Desné, S., Berchery, D., Rossignol, G., Poiree, B., Meslier, M., et al. Prevalence, risk factors and clinical implications of malnutrition in French comprehensive cancer centres. Br J Cancer 102 (2010), 966–971.
4. Oh, S.W., Park, C.Y., Lee, E.S., Yoon, Y.S., Lee, E.S., Park, S.S., et al. Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study. Breast Cancer Res, 13, 2011, R34.
5. Flood, A., Mai, V., Pfeiffer, R., Kahle, L., Remaley, A.T., Lanza, E., et al. Elevated serum concentrations of insulin and glucose increase risk of recurrent colorectal adenomas. Gastroenterology 133 (2007), 1423–1429.
6. Arends, J., Bodoky, G., Bozzetti, F., Fearon, K., Muscaritoli, M., Selga, G., et al., DGEM (German Society for Nutritional Medicine), ESPEN (European Society for Parenteral and Enteral Nutrition). ESPEN guidelines on enteral nutrition: non-surgical oncology. Clin Nutr 25 (2006), 245–259.
7. Arends, J., Bodoky, G., Bozzetti, F., Fearon, K., Muscaritoli, M., Selga, G., et al., DGEM (German Society for Nutritional Medicine), ESPEN (European Society for Parenteral and Enteral Nutrition). ESPEN guidelines on parenteral nutrition: non-surgical oncology. Clin Nutr 28 (2009), 445–454.
8. Kushi, L.H., Doyle, C., McCullough, M., Rock, C.L., Demark-Wahnefried, W., Bandera, E.V., et al. American cancer society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 62 (2012), 30–67.
9. August, D.A., Huhmann, M.B., American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. A.S.P.E.N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. J Parenter Enter Nutr 33 (2009), 472–500.
10. Attar, A., Malka, D., Sabaté, J.M., Bonnetain, F., Lecomte, T., Aparicio, T., et al. Malnutrition is high and underestimated during chemotherapy in gastrointestinal cancer: an AGEO prospective cross-sectional multicenter study. Nutr Cancer 64 (2012), 535–542.
11. van Wayenburg, C.A., Rasmussen-Conrad, E.L., van den Berg, M.G., Merkx, M.A., van Staveren, W.A., van Weel, C., et al. Weight loss in head and neck cancer patients little noticed in general practice. J Prim Health Care 2 (2010), 16–21.
12. Hébuterne, X., Lemarié, E., Michallet, M., de Montreuil, C.B., Schneider, S.M., Goldwasser, F., Prevalence of malnutrition and current use of nutrition support in patients with cancer. J Parenter Enter Nutr 38 (2014), 196–204.
13. Churm, D., Andrew, I.M., Holden, K., Hildreth, A.J., Hawkins, C., A questionnaire study of the approach to the anorexia-cachexia syndrome in patients with cancer by staff in a district general hospital. Support Care Cancer 17 (2009), 503–507.
14. Spiro, A., Baldwin, C., Patterson, A., Thomas, J., Andreyev, H.J., The views and practice of oncologists towards nutritional support in patients receiving chemotherapy. Br J Cancer 95 (2006), 431–434.
15. Guyatt, G.H., Oxman, A.D., Kunz, R., Falck-Ytter, Y., Vist, G.E., Liberati, A., et al. Rating quality of evidence and strength of recommendations: Going from evidence to recommendations. BMJ 336:7652 (2008), 1049–1051.
16. Guyatt, G.H., Oxman, A.D., Vist, G.E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., et al. Rating quality of evidence and strength of recommendations GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336 (2008), 924–926.
17. Jaeschke, R., Guyatt, G.H., Dellinger, P., Schünemann, H., Levy, M.M., Kunz, R., et al. Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ, 337, 2008, a744.
18. Guyatt, G.H., Oxman, A.D., Schünemann, H.J., Tugwell, P., Knottnerus, A., GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol 64 (2011), 380–382.
19. Kushner, R.F., Barriers to providing nutrition. Prev Med 24 (1995), 546–552.
20. DeLegge, M.H., Kelly, A.T., State of nutrition support teams. Nutr Clin Prac 28 (2013), 691–697.
21. Fearon, K., Strasser, F., Anker, S.D., Bosaeus, I., Bruera, E., Fainsinger, R.L., et al. Definition and classification of cancer cachexia: an international consensus framework. Lancet Oncol 12 (2011), 489–495.
22. Jensen, G.L., Mirtallo, J., Compher, C., Dhaliwal, R., Forbes, A., Grijalba, R.F., et al. Adult starvation and disease-related malnutrition: a proposal for etiology-based diagnosis in the clinical practice setting from the international consensus guideline committee. J Parenter Enter Nutr 34 (2010), 156–159.
23. Muscaritoli, M., Anker, S.D., Argilés, J., Aversa, Z., Bauer, J.M., Biolo, G., et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics. Clin Nutr 29 (2010), 154–159.
24. Dechaphunkul, T., Martin, L., Alberda, C., Olson, K., Baracos, V., Gramlich, L., Crit Rev Oncol Hematol 88 (2013), 459–476.
25. Martin, L., Senesse, P., Gioulbasanis, I., Antoun, S., Bozzetti, F., Deans, C., et al. Diagnostic criteria for the classification of cancer-associated weight loss. J Clin Oncol 33 (2015), 90–99.
26. Baracos, V., Kazemi-Bajestani, S.M., Clinical outcomes related to muscle mass in humans with cancer and catabolic illnesses. Int J Biochem Cell Biol 45 (2013), 2302–2308.
27. Martin, L., Birdsell, L., Macdonald, N., Reiman, T., Clandinin, M.T., McCargar, L.J., et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31 (2013), 1539–1547.
28. Dewys, W.D., Begg, C., Lavin, P.T., Band, P.R., Bennett, J.M., Bertino, J.R., et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern cooperative oncology group. Am J Med 69 (1980), 491–497.
29. Jang, R.W., Caraiscos, V.B., Swami, N., Banerjee, S., Mak, E., Kaya, E., et al. Simple prognostic model for patients with advanced cancer based on performance status. J Oncol Pract 10 (2014), e335–e341.
30. Rossi-Fanelli, F., Franchi, F., Mulieri, M., Cangiano, C., Cascino, A., Ceci, F., et al. Effect of energy substrate manipulation on tumour cell proliferation in parenterally fed cancer patients. Clin Nutr 10 (1991), 228–232.
31. Bossola, M., Pacelli, F., Rosa, F., Tortorelli, A., Doglietto, G.B., Does nutrition support stimulate tumor growth in humans?. Nutr Clin Pract 26 (2011), 174–180.
32. Lacey, K., Pritchett, E., Nutrition care process and model: ADA adopts road map to quality care and outcomes management. J Am Diet Assoc 103 (2003), 1061–1072 Erratum in: J Am Diet Assoc 2003; 103: 1293.
33. Writing Group of the Nutrition Care Process/Standardized Language Committee, Nutrition care process part II: using the International Dietetics and Nutrition Terminology to document the nutrition care process. J Am Diet Assoc 108 (2008), 1287–1293.
34. Muscaritoli, M., Molfino, A., Gioia, G., Laviano, A., Rossi Fanelli, F., The “parallel pathway”: a novel nutritional and metabolic approach to cancer patients. Intern Emerg Med 6 (2011), 105–112.
35. Correia, M.I., Hegazi, R.A., Higashiguchi, T., Michel, J.P., Reddy, B.R., Tappenden, K.A., et al. Evidence-based recommendations for addressing malnutrition in health care: an updated strategy from the feed M.E. Global Study Group. J Am Med Dir Assoc 15 (2014), 544–550.
36. Meijers, J.M., Tan, F., Schols, J.M., Halfens, R.J., Nutritional care; do process and structure indicators influence malnutrition prevalence over time?. Clin Nutr 33 (2014), 459–465.
37. McMillan, D.C., The systemic inflammation-based glasgow prognostic score: a decade of experience in patients with cancer. Cancer Treat Rev 39 (2013), 534–540.
38. Pan, H., Cai, S., Ji, J., Jiang, Z., Liang, H., Lin, F., et al. The impact of nutritional status, nutritional risk, and nutritional treatment on clinical outcome of 2248 hospitalized cancer patients: a multi-center, prospective cohort study in Chinese teaching hospitals. Nutr Cancer 65 (2013), 62–70.
39. Isenring, E., Elia, M., Which screening method is appropriate for older cancer patients at risk for malnutrition?. Nutrition 31 (2015), 594–597.
40. Geiker, N.R., Hørup Larsen, S.M., Stender, S., Astrup, A., Poor performance of mandatory nutritional screening of in-hospital patients. Clin Nutr 31 (2012), 862–867.
41. http://www.healthcareimprovementscotland.org/our_work/patient_safety/improving_nutritional_care/nutritional_care_standards.aspx.
42. Baldwin, C., Spiro, A., McGough, C., Norman, A.R., Gillbanks, A., Thomas, K., et al. Simple nutritional intervention in patients with advanced cancers of the gastrointestinal tract, non-small cell lung cancers or mesothelioma and weight loss receiving chemotherapy: a randomised controlled trial. J Hum Nutr Diet 24 (2011), 431–440.
43. Baldwin, C., Weekes, C.E., Dietary advice with or without oral nutritional supplements for disease-related malnutrition in adults. Cochrane Database Syst Rev, 9, 2011 Sep 7, CD002008.
44. Ravasco, P., Monteiro-Grillo, I., Vidal, P.M., Camilo, M.E., Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol 23 (2005), 1431–1438.
45. Ravasco, P., Monteiro-Grillo, I., Marques Vidal, P., Camilo, M.E., Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head Neck 27 (2005), 659–668.
46. Del Fabbro, E., Hui, D., Dalal, S., Dev, R., Nooruddin, Z.I., Bruera, E., Clinical outcomes and contributors to weight loss in a cancer cachexia clinic. J Palliat Med 14 (2011), 1004–1008.
47. Gagnon, B., Murphy, J., Eades, M., Lemoignan, J., Jelowicki, M., Carney, S., et al. A prospective evaluation of an interdisciplinary nutrition-rehabilitation program for patients with advanced cancer. Curr Oncol 20 (2013), 310–318.
48. Detsky, A.S., McLaughlin, J.R., Baker, J.P., Johnston, N., Whittaker, S., Mendelson, R.A., et al. What is subjective global assessment of nutritional status?. J Parenter Enter Nutr 11 (1987), 8–13.
49. Bauer, J., Capra, S., Ferguson, M., Use of the scored patient-generated subjective global assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 56 (2002), 779–785.
50. Gabrielson, D.K., Scaffidi, D., Leung, E., Stoyanoff, L., Robinson, J., Nisenbaum, R., et al. Use of an abridged scored patient-generated subjective global assessment (abPG-SGA) as a nutritional screening tool for cancer patients in an outpatient setting. Nutr Cancer 65 (2013), 234–239.
51. Isenring, E., Cross, G., Kellett, E., Koczwara, B., Daniels, L., Nutritional status and information needs of medical oncology patients receiving treatment at an Australian public hospital. Nutr Cancer 62 (2010), 220–228.
52. Ribaudo, J.M., Cella, D., Hahn, E.A., Lloyd, S.R., Tchekmedyian, N.S., Von Roenn, J., et al. Re-validation and shortening of the functional assessment of anorexia/cachexia therapy (FAACT) questionnaire. Qual Life Res 9 (2000), 1137–1146.
53. Aaronson, N.K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N.J., et al. The european organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993), 365–376.
54. Stubbs, R.J., Hughes, D.A., Johnstone, A.M., Rowley, E., Reid, C., Elia, M., et al. The use of visual analogue scales to assess motivation to eat in human subjects: a review of their reliability and validity with an evaluation of new hand-held computerized systems for temporal tracking of appetite ratings. Br J Nutr 84 (2000), 405–415.
55. Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T., et al. Toxicity and response criteria of the Eastern cooperative oncology group. Am J Clin Oncol 5 (1982), 649–655.
56. Yates, J.W., Chalmer, B., McKegney, F.P., Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 45 (1980), 2220–2224.
57. Bozzetti, F., Mori, V., Nutritional support and tumour growth in humans: a narrative review of the literature. Clin Nutr 28 (2009), 226–230.
58. Knox, L.S., Crosby, L.O., Feurer, I.D., Buzby, G.P., Miller, C.L., Mullen, J.L., Energy expenditure in malnourished cancer patients. Ann Surg 197 (1983), 152–161.
59. Dempsey, D.T., Feurer, I.D., Knox, L.S., Crosby, L.O., Buzby, G.P., Mullen, J.L., Energy expenditure in malnourished gastrointestinal cancer patients. Cancer 53 (1984), 1265–1273.
60. Bosaeus, I., Daneryd, P., Svanberg, E., Lundholm, K., Dietary intake, resting energy expenditure in relation to weight loss in unselected cancer patients. Int J Cancer 93 (2001), 380–383.
61. Cao, D.X., Wu, G.H., Zhang, B., Quan, Y.J., Wei, J., Jin, H., et al. Resting energy expenditure and body composition in patients with newly detected cancer. Clin Nutr 29 (2010), 72–77.
62. Hansell, D.T., Davies, J.W., Burns, H.J., Effects of hepatic metastases on resting energy expenditure in patients with colorectal cancer. Br J Surg 73 (1986), 659–662.
63. Fredrix, E.W., Soeters, P.B., Wouters, E.F., Deerenberg, I.M., von Meyenfeldt, M.F., Saris, W.H., Effect of different tumor types on resting energy expenditure. Cancer Res 51 (1991), 6138–6141.
64. Moses, A.W., Slater, C., Preston, T., Barber, M.D., Fearon, K.C., Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with N-3 fatty acids. Br J Cancer 90 (2004), 996–1002.
65. Gibney, E., Elia, M., Jebb, S.A., Murgatroyd, P., Jennings, G., Total energy expenditure in patients with small-cell lung cancer: results of a validated study using the bicarbonate-urea method. Metabolism 46 (1997), 1412–1417.
66. Staal-van den Brekel, A.J., Schols, A.M., Dentener, M.A., ten Velde, G.P., Buurman, W.A., Wouters, E.F., The effects of treatment with chemotherapy on energy metabolism and inflammatory mediators in small-cell lung carcinoma. Br J Cancer 76 (1997), 1630–1635.
67. Silver, H.J., Dietrich, M.S., Murphy, B.A., Changes in body mass, energy balance, physical function, and inflammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction chemotherapy. Head Neck 29 (2007), 893–900.
68. Cereda, E., Turrini, M., Ciapanna, D., Marbello, L., Pietrobelli, A., Corradi, E., Assessing energy expenditure in cancer patients: a pilot validation of a new wearable device. J Parenter Enter Nutr 31 (2007), 502–507.
69. Bencini, L., Di Leo, A., Pozzessere, D., Bozzetti, F., Total energy expenditure in patients with advanced solid tumours: a preliminary report. Nutr Ther Met 26 (2008), 45–47.
70. WHO, Joint FAO/WHO/UNU expert consultation. Energy and protein requirements. WHO Technical Report Series 724, 1985, WHO, Geneva.
71. Schofield, W.N., Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr Clin Nutr 39:Suppl. 1 (1985), 5–41.
72. Baracos, V.E., Skeletal muscle anabolism in patients with advanced cancer. Lancet Oncol 16 (2015), 13–14.
73. Nitenberg, G., Raynard, B., Nutritional Support of the cancer patient: issues and dilemmas. Crit Rev Oncol Hematol 34 (2000), 137–168.
74. Barrera, R., Nutritional support in cancer patients. J Parent Enter Nutr 26:5 Suppl. (2002), 563–571.
75. Baracos, V.E., Meeting the aminoacid requirements for protein anabolism in cancer cachexia. Mantovani, G., (eds.) Cachexia and wasting. A modern approach, 2006, Springer Milan, 631–634.
76. Guadagni, M., Biolo, G., Effects of inflammation and/or inactivity on the need for dietary protein. Curr Opin Clin Nutr Metab Care 12 (2009), 617–622.
77. Haran, P.H., Rivas, D.A., Fielding, Role and potential mechanisms of anabolic resistance in sarcopenia. J Cachexia Sarcopenia Muscle 3 (2012), 157–162.
78. Deutz, N.E., Bauer, J.M., Barazzoni, R., Biolo, G., Boirie, Y., Bosy-Westphal, A., et al. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN expert group. Clin Nutr 33 (2014), 929–936.
79. Bauer, J., Biolo, G., Cederholm, T., Cesari, M., Cruz-Jentoft, A.J., Morley, J.E., et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE study group. J Am Med Dir Assoc 14 (2013), 542–559.
80. Eden, E., Edstrom, S., Bennegard, K., Schersten, T., Lundholm, K., Glucose flux in relation to energy expenditure in malnourished patients with and without cancer during periods of fasting and feeding. Cancer Res, 44, 1984, 1718e24.
81. Lindmark, L., Bennegård, K., Edén, E., Svaninger, G., Ternell, M., Lundholm, K., Thermic effect and substrate oxidation in response to intravenous nutrition in cancer patients who lose weight. Ann Surg 204 (1986), 628–636.
82. Pirat, A., Tucker, A.M., Taylor, K.A., Jinnah, R., Finch, C.G., Canada, T.D., et al. Comparison of measured versus predicted energy requirements in critically ill cancer patients. Respir Care 54 (2009), 487–494.
83. Richards, E.W., Long, C.L., Nelson, K.M., Tohver, O.K., Pinkston, J.A., Navari, R.M., et al. Protein turnover in advanced lung cancer patients. Metabolism 42 (1993), 291–296.
84. MacDonald, A.J., Johns, N., Stephens, N.A., Greig, C., Ross, J.A., Small, A.C., et al. Habitual myofibrillar protein synthesis is normal in patients with upper GI cancer cachexia. Clin Cancer Res 21 (2015), 1734–1740.
85. Bozzetti, F., Bozzetti, V., Is the intravenous administration of amino acid adequate in cancer patients? A critical appraisal of literature. Clin Nutr 32 (2013), 142–146.
86. Winter, A., Macadams, J., Chevalier, S., Normal protein anabolic response to hyperaminoacidemia in insulin-resistant patients with lung cancer cachexia. Clin Nutr 31 (2012), 765–773.
87. Martin, W.F., Armstrong, L.E., Rodriguez, N.R., Dietary protein intake and renal function. Nutr Metab Lond, 2, 2005 Sep 20, 25.
88. Cano, N., Fiaccadori, E., Tesinsky, P., Toigo, G., Druml, W., DGEM (German Society for Nutritional Medicine), et al. ESPEN guidelines on enteral nutrition: adult renal failure. Clin Nutr 25 (2006), 295–310.
89. Tayek, J.A., Bistrian, B.R., Hehir, D.J., Martin, R., Moldawer, L.L., Blackburn, G.L., Improved protein kinetics and albumin synthesis by branched chain aminoacid-enriched total parenteral nutrition in cancer cachexia. A prospective randomized crossover trial. Cancer 58 (1986), 147–157.
90. Hunter, D.C., Weintraub, M., Blackburn, G.L., Bistrian, B.R., Branched chain amino acids as the protein component of parenteral nutrition in cancer cachexia. Br J Surg 76 (1989), 149–153.
91. Deutz, N.E., Safar, A., Schutzler, S., Memelink, R., Ferrando, A., Spencer, H., et al. Muscle protein synthesis in cancer patients can be stimulated with a specially formulated medical food. Clin Nutr 30 (2011), 759–768.
92. Kuhn, K.S., Muscaritoli, M., Wischmeyer, P., Stehle, P., Glutamine as indispensable nutrient in oncology: experimental and clinical evidence. Eur J Clin Nutr 49 (2010), 197–210.
93. Arcidiacono, B., Iiritano, S., Nocera, A., Possidente, K., Nevolo, M.T., Ventura, V., et al. Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res, 2012, 2012, 789174, 10.1155/2012/789174.
94. Waterhouse, C., Kemperman, J.H., Carbohydrate metabolism in subjects with cancer. Cancer Res 31 (1971), 1273–1278.
95. Legaspi, A., Jeevenandam, M., Fletcher Starnes, H. Jr., Brennan, M.F., Whole lipid and energy metabolism in the cancer patient. Metabolism 36 (1987), 958–963.
96. Selberg, O., McMillan, D.C., Preston, T., Carse, H., Shenkin, A., Burns, H.J., Palmitate turnover and its response to glucose infusion in weight-losing cancer patients. Clin Nutr 9 (1990), 150–156.
97. Arbeit, M.A., Lees, D.A., Corsey, R., Brennan, M.F., Resting energy expenditure in controls and cancer patients with localized and diffuse disease. Ann Surg 199 (1984), 292–298.
98. Shaw, J.F., Wolfe, R.R., Fatty acid and glycerol kinetics in septic patients and in patients with gastrointestinal cancer. Ann Surg 205 (1987), 368–376.
99. Hansell, D.T., Davies, J.W.L., Burns, H.J.G., Shenkin, A., The oxidation of body fuel stores in cancer patients. Ann Surg 204 (1986), 638–642.
100. Korber, J., Pricelius, S., Heidrich, M., Muller, M.J., Increased lipid utilization in weight-losing and weight-stable cancer patients with normal body weight. Eur J Clin Nutr 53 (1999), 740–745.
101. Vanek, V.W., Borum, P., Buchman, A., Fessler, T.A., Howard, L., Shenkin, A., et al. Novel Nutrient Task Force, Parenteral Multi-Vitamin and Multi–Trace Element Working Group, American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. A.S.P.E.N. position paper: recommendations for changes in commercially available parenteral multivitamin and multi-trace element products. Nutr Clin Pract 27 (2012), 440–491.
102. Cabrero, A., Laguna, J.C., Vazquez, M., Peroxisome proliferator-activated receptors and the control of inflammation. Curr Drug Targets Inflamm Allergy 1 (2002), 243–248.
103. Zhao, Y., Joshi-Barve, S., Barve, S., Chen, L.H., Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. J Am Coll Nutr 23 (2004), 71–786.
104. Gamble, J.L., The Harvey Lectures, Series XLIII, 1946-1947: physiological information gained from studies on the life raft ration. Nutr Rev 47 (1989), 199–201.
105. Bloom, W.L., Inhibition of salt excretion by carbohydrate. Arch Intern Med 109 (1962), 26–32.
106. Ferrannini, E., De Fronzo, R.A., Renal handling of insulin in man. Contrib Nephrol 43 (1984), 49–53.
107. Rudman, D., Millikan, W.J., Richardson, T.J., Bixler, T.J. 2nd, Stackhouse, J., McGarrity, W.C., Elemental balances during intravenous hyperalimentation of underweight adult subjects. J Clin Invest 55 (1975), 94–104.
108. Fan, S.T., Lau, W.Y., Wong, K.K., Chan, P.M., Preoperative parenteral nutr ition in esophageal cancer: a prospective randomized clinical trial. Clin Nutr 8 (1989), 23–27.
109. Bozzetti, F., Ammatuna, M., Migliavacca, S., Facchetti, G., Cozzaglio, L., Morabito, A., et al. Comparison of glucose versus fat solutions in cancer patients: a controlled cross-over study. Clin Nutr 9 (1990), 325–330.
110. Gray, G.E., Meguid, M.M., Can total parenteral nutrition reverse hypoalbuminemia in oncology patients?. Nutrition 6 (1990), 225–228.
111. Moser, A.M., Streeten, D.H.P., Disorders of the neurohypophysis. Isselhacher, K.J., et al. (eds.) Harrison's principles of internal medicine, 13th ed., 1994, McGraw-Hil, New York, pp1921–1930.
112. Steiner, N., Bruera, E., Methods of hydration in palliative care patients. J Palliat Care 14 (1998), 6–13.
113. Kerndt, P., Naughton, J., Driscoll, G., Loxterkamp, A., Fasting: the history, pathophysiology and complications. West J Med 137 (1982), 379–399.
114. Bruera, E., Miller, M.J., Kuehn, N., MacEachern, T., Hanson, J., Estimate of survival of patients admitted to a palliative care unit: a prospective study. J Pain Symptoms Manage 7 (1992), 82–86.
115. Shenkin, A., The key role of micronutrients. Clin Nutr 25 (2006), 1–13.
116. Giovannucci, E., Chan, A.T., Role of vitamin and mineral supplementation and aspirin use in cancer survivors. J Clin Oncol 28 (2010), 4081–4085.
117. Mamede, A.C., Tavares, S.D., Abrantes, A.M., Trindade, J., Maia, J.M., Botelho, M.F., The role of vitamins in cancer: a review. Nutr Cancer 63 (2011), 479–494.
118. Ströhle, A., Zänker, K., Hahn, A., Nutrition in oncology: the case of micronutrients (review). Oncol Rep 24 (2010), 815–828.
119. Rock, C.L., Doyle, C., Demark-Wahnefried, W., Meyerhardt, J., Courneya, K.S., Schwartz, A.L., et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 62 (2012), 243–274.
120. Biesalski, H.K., Mikronährstoffsupplemente bei onkologischen Patienten. Onkologe 14 (2008), 45–57.
121. Zürcher, G., Gola, U., Biesalski, H.K., Antioxidanzien bei Krebs. Schweiz Z für Ernährungsmedizin 4 (2007), 17–19.
122. Norman, H.A., Butrum, R.R., Feldman, E., Heber, D., Nixon, D., Picciano, M.F., et al. The role of dietary supplements during cancer therapy. J Nutr 133:Suppl. 11 (2003), S3794–S3799.
123. WHO/FAO: http://www.who.int/nutrition/topics/nutrecomm/en/.
124. EFSA: http://www.efsa.europa.eu/en/topics/topic/drv.
125. The Nordic Nutrition Recommendations: http://www.norden.org/en/theme/nordic-nutrition-recommendation.
126. Institute of Medicine: http://www.nap.edu/search/?topic=381&rpp=20&ft=1&term=Dietary+Reference+Intakes.
127. Deutsche Gesellschaft für Ernährung, Österreichische Gesellschaft für Ernährung, Schweizerische Gesellschaft für Ernährungsforschung, Schweizerische Vereinigung für Ernährung, (eds.) Referenzwerte für die Nährstoffzufuhr, 2015 Bonn, 2. Auflage, 1. Ausgabe.
128. Biesalski, K.H., Bischoff, S.C., Boehles, H.J., Muelhoefer, A., Water, electrolytes, vitamins and trace elements –guidelines on parenteral nutrition, Chapter 7. Ger Med Sci, 7, 2009, 21.
129. Akutsu, Y., Kono, T., Uesato, M., Hoshino, I., Murakami, K., Fujishiro, T., et al. Are additional trace elements necessary in total parenteral nutrition for patients with esophageal cancer receiving cisplatin-based chemotherapy?. Biol Trace Elem Res 150 (2012), 109–115.
130. Łuczyńska, A., Kaaks, R., Rohrmann, S., Becker, S., Linseisen, J., Buijsse, B., et al. Plasma 25-hydroxyvitamin D concentration and lymphoma risk: results of the European prospective investigation into Cancer and nutrition. Am J Clin Nutr 98 (2013), 827–838.
131. Drake, M.T., Maurer, M.J., Link, B.K., Habermann, T.M., Ansell, S.M., Micallef, I.N., et al. Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. J Clin Oncol 28:27 (2010), 4191–4198.
132. Arends, J., Vitamin D in oncology. Forsch Komplementmed 18 (2011), 176–184.
133. Zgaga, L., Theodoratou, E., Farrington, S.M., Din, F.V., Ooi, L.Y., Glodzik, D., et al. Plasma vitamin D concentration influences survival outcome after a diagnosis of colorectal cancer. J Clin Oncol 32 (2014), 2430–2439.
134. Rose, A.A., Elser, C., Ennis, M., Goodwin, P.J., Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis. Breast Cancer Res Treat 141 (2013), 331–339.
135. Bolland, M.J., Grey, A., Gamble, G.D., Reid, I.R., The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: trial sequential meta-analysis. Lancet Diabetes Endocrinol 2 (2014), 307–320.
136. Autier, P., Boniol, M., Pizot, C., Mullie, P., Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2 (2014), 76–89.
137. Horneber, M., Bueschel, G., Dennert, G., Less, D., Ritter, E., Zwahlen, M., How many cancer patients use complementary and alternative medicine: a systematic review and meta-analysis. Integr Cancer Ther 11 (2012), 187–203.
138. Farina, E.K., Austin, K.G., Lieberman, H.R., Concomitant dietary supplement and prescription medication use is prevalent among US adults with doctor-informed medical conditions. J Acad Nutr Diet 114 (2014), 1784–1790.
139. Bjelakovic, G., Nikolova, D., Gluud, L.L., Simonetti, R.G., Gluud, C., Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297 (2007), 842–857.
140. Lawson, K.A., Wright, M.E., Subar, A., Mouw, T., Hollenbeck, A., Schatzkin, A., et al. Multivitamin use and risk of prostate cancer in the national institutes of health-AARP diet and health study. J Natl Cancer Inst 99 (2007), 754–764.
141. Ng, K., Meyerhardt, J.A., Chan, J.A., Niedzwiecki, D., Hollis, D.R., Saltz, L.B., et al. Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol 28 (2010), 4354–4363.
142. Ristow, M., Zarse, K., Oberbach, A., Klöting, N., Birringer, M., Kiehntopf, M., et al. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci U. S. A 106 (2009), 8665–8670.
143. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group, The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330 (1994), 1029–1035.
144. Klein, E.A., Thompson, I.M. Jr., Tangen, C.M., Crowley, J.J., Lucia, M.S., Goodman, P.J., et al. Vitamin E and the risk of prostate cancer: the selenium and vitamin E cancer prevention trial (SELECT). JAMA 306 (2011), 1549–1556.
145. Kenfield, S.A., Van Blarigan, E.L., DuPre, N., Stampfer, M.J., Giovannucci, E., Chan, J.M., Selenium supplementation and prostate cancer mortality. J Natl Cancer Inst, 107, 2014, 360.
146. Wang, L., Sesso, H.D., Glynn, R.J., Christen, W.G., Bubes, V., Manson, J.E., et al. Vitamin E and C supplementation and risk of cancer in men: posttrial follow-up in the Physicians' Health Study II randomized trial. Am J Clin Nutr 100 (2014), 915–923.
147. Bozzetti, F., Nutritional support in patients with oesophageal cancer. Support Care Cancer 18:Suppl 2 (2010), S41–S50.
148. Skipworth, R.J., Stewart, G.D., Dejong, C.H., Preston, T., Fearon, K.C., Pathophysiology of cancer cachexia: much more than host-tumour interaction?. Clin Nutr 26 (2007), 667–676.
149. Eaton, C.B., McBride, P.E., Gans, K.A., Underbakke, G.L., Teaching nutrition skills to primary care practitioners. J Nutr 133 (2003), 563S–566S.
150. Brown, T., Findlay, M., von Dincklage, J., Davidson, W., Hill, J., Isenring, E., et al. Using a wiki platform to promote guidelines internationally and maintain their currency: evidence-based guidelines for the nutritional management of adult patients with head and neck cancer. J Hum Nutr Diet 26 (2013), 182–190.
151. Clutter Snyder, D., Sloane, R., Haines, P.S., Miller, P., Clipp, E.C., Morey, M.C., et al. The diet quality index-revised: a tool to promote and evaluate dietary change among older cancer survivors enrolled in a home-based intervention trial. J Am Diet Assoc 107 (2007), 1519–1529.
152. Isenring, E., Zabel, R., Bannister, M., Brown, T., Findlay, M., Kiss, N., et al. Update of the evidence based guidelines for the nutritional management of patients receiving radiation therapy and/or chemotherapy. Nutr Diet 70 (2013), 312–324.
153. Baldwin, C., Spiro, A., Ahern, R., Emery, P.W., Oral nutrition therapy in malnourished patients with cancer: a systematic review and meta-analysis. J Natl Cancer Inst 104 (2012), 371–385.
154. Bourdel-Marchasson, I., Blanc-Bisson, C., Doussau, A., Germain, C., Blanc, J.F., Dauba, J., et al. Nutritional advice in older patients at risk of malnutrition during treatment for chemotherapy: a two-year randomized controlled trial. PLoS One, 9, 2014, e108687.
155. Langius, J.A., Zandbergen, M.C., Eerenstein, S.E., van Tulder, M.W., Leemans, C.R., Kramer, M.H., et al. Effect of nutrition therapy on nutritional status, quality of life and mortality in patients with head and neck cancer receiving (chemo)radiotherapy: a systematic review. Clin Nutr 32 (2013), 671–678.
156. Halfdanarson, T.R., Thordardottir, E., West, C.P., Jatoi, A., Does dietary counselling improve quality of life in cancer patients? A systematic review and meta-analysis. J Support Oncol 6 (2008), 234–237.
157. Ravasco, P., Monteiro-Grillo, I., Camilo, M., Individualized nutrition intervention is of major benefit to colorectal cancer patients: long-term follow-up of a randomized controlled trial of nutritional therapy. Am J Clin Nutr 96 (2012), 1346–1353.
158. Huebner, J., Marienfeld, S., Abbenhardt, C., Ulrich, C., Muenstedt, K., Micke, O., et al. Counseling patients on cancer diets: a review of the literature and recommendations for clinical practice. Anticancer Res 34 (2014), 39–48.
159. Arends, J., Baumann, F., Lampe, H., Paul, A., What we do not take as (sufficiently) true. Onkologie 35:Suppl 5 (2012), 12–20.
160. Dansinger, M.L., Gleason, J.A., Griffith, J.L., Selker, H.P., Schaefer, E.J., Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA 293 (2005), 43–53.
161. Ye, F., Li, X.J., Jiang, W.L., Sun, H.B., Liu, J., Efficacy of and patient compliance with a ketogenic diet in adults with intractable epilepsy: a meta-analysis. J Clin Neurol 11 (2015), 26–31.
162. Schmidt, M., Pfetzer, N., Schwab, M., Strauss, I., Kämmerer, U., Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: a pilot trial. Nutr Metab (Lond), 8, 2011, 54.
163. Allen, B.G., Bhatia, S.K., Buatti, J.M., Brandt, K.E., Lindholm, K.E., Button, A.M., et al. Ketogenic diets enhance oxidative stress and radio-chemo-therapy responses in lung cancer xenografts. Clin Cancer Res 19 (2013), 3905–3913.
164. Bozzetti, F., Zupec-Kania, B., Toward a cancer-specific diet. Clin Nutr 35 (2016), 1188–1195.
165. Vidali, S., Aminzadeh, S., Lambert, B., Rutherford, T., Sperl, W., Kofler, B., et al. Mitochondria: the ketogenic diet–A metabolism-based therapy. Int J Biochem Cell Biol 63 (2015), 55–59.
166. Nagamatsu, S., Sawa, H., Wakizaka, A., Hoshino, T., Expression of facilitative glucose transporter isoforms in human brain tumors. J Neurochem 61 (1993), 2048–2053.
167. Haber, R.S., Weiser, K.R., Pritsker, A., Reder, I., Burstein, D.E., GLUT1 glucose transporter expression in benign and malignant thyroid nodules. Thyroid 7 (1997), 363–367.
168. Fukuzumi, M., Hamakawa, H., Onishi, A., Sumida, T., Tanioka, H., Gene expression of GLUT isoforms and VHL in oral squamous cell carcinoma. Cancer Lett 161 (2000), 133–140.
169. Noguchi, Y., Marat, D., Saito, A., Yoshikawa, T., Doi, C., Fukuzawa, K., et al. Expression of facilitative glucose transporters in gastric tumors. Hepatogastroenterology 46 (1999), 2683–2689.
170. Rudlowski, C., Becker, A.J., Schroder, W., Rath, W., Büttner, R., Moser, M., GLUT1 messenger RNA and protein induction relates to the malignant transformation of cervical cancer. Am J Clin Pathol 120 (2003), 691–698.
171. Macheda, M.L., Rogers, S., Best, J.D., Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 202 (2005), 654–662.
172. Chang, S., Lee, S., Lee, C., Kim, J.I., Kim, Y., Expression of the human erythrocyte glucose transporter in transitional cell carcinoma of the bladder. Urology 55 (2000), 448–452.
173. Palit, V., Phillips, R.M., Puri, R., Shah, T., Bibby, M.C., Expression of HIF-1alpha and Glut-1 in human bladder cancer. Oncol Rep 14 (2005), 909–913.
174. Elstrom, R.L., Bauer, D.E., Buzzai, M., Karnauskas, R., Harris, M.H., Plas, D.R., et al. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 64 (2004), 3892–3899.
175. Ho, V.W., Leung, K., Hsu, A., Luk, B., Lai, J., Shen, S.Y., et al. A low carbohydrate, high protein diet slows tumor growth and prevents cancer initiation. Cancer Res 71 (2011), 4484–4493.
176. Poff, A.M., Ari, C., Seyfried, T.N., D'Agostino, D.P., The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer. PLoS One, 8, 2013, e65522.
177. Rieger, J., Bähr, O., Maurer, G.D., Hattingen, E., Franz, K., Brucker, D., et al. ERGO: a pilot study of ketogenic diet in recurrent glioblastoma. Int J Oncol 44 (2014), 1843–1852.
178. Arends, J., Malignant tumors – Transketolase-like 1 (TKTL 1) – ketogenic diet. Aktuel Ernahrungsmed 33 (2008), 80–81.
179. Breitkreutz, R., Tesdal, K., Jentschura, D., Haas, O., Leweling, H., Holm, E., Effects of a high-fat diet on body composition in cancer patients receiving chemotherapy: a randomized controlled study. Wien Klin Wochenschr 117 (2005), 685–692.
180. Raffaghello, L., Lee, C., Safdie, F.M., Wei, M., Madia, F., Bianchi, G., et al. Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proc Natl Acad Sci U. S. A 105 (2008), 8215–8220.
181. Lee, C., Raffaghello, L., Brandhorst, S., Safdie, F.M., Bianchi, G., Martin-Montalvo, A., et al. Fasting cycles retard growth of tumors and sensitize a rage of cancer cell types to chemotherapy. Sci Transl Med, 4, 2012, 124ra27.
182. Safdie, F., Brandhorst, S., Wei, M., Wang, W., Lee, C., Hwang, S., et al. Fasting enhances the response of glioma to chemo- and radiotherapy. PLoS One, 7, 2012, e44603.
183. Caffa, I., Longo, V.D., Nencioni, A., Fasting plus tyrosine kinase inhibitors in cancer. Aging (Albany NY) 7 (2015), 1026–1027.
184. Laviano, A., Rossi Fanelli, F., Toxicity in chemotherapy–when less is more. N Engl J Med 366 (2012), 2319–2320.
185. Safdie, F.M., Dorff, T., Quinn, D., Fontana, L., Wei, M., Lee, C., et al. Fasting and cancer treatment in humans: a case series report. Aging (Albany NY) 1 (2009), 988–1007.
186. de Groot, S., Vreeswijk, M.P., Welters, M.J., Gravesteijn, G., Boei, J.J., Jochems, A., et al. The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study. BMC Cancer, 15, 2015, 652.
187. Corry, J., Poon, W., McPhee, N., Milner, A.D., Cruickshank, D., Porceddu, S.V., et al. Randomized study of percutaneous endoscopic gastrostomy versus nasogastric tubes for enteral feeding in head and neck cancer patients treated with (chemo)radiation. J Med Imaging Radiat Oncol 52 (2008), 503–510.
188. Nugent, B., Parker, M.J., McIntyre, I.A., Nasogastric tube feeding and percutaneous endoscopic gastrostomy tube feeding in patients with head and neck cancer. J Hum Nutr Diet 23 (2010), 277–284.
189. Sheth, C.H., Sharp, S., Walters, E.R., Enteral feeding in head and neck cancer patients at a UK cancer centre. J Hum Nutr Diet 26 (2013), 421–428.
190. Bozzetti, F., Santarpia, L., Pironi, L., Thul, P., Klek, S., Gavazzi, C., et al. The prognosis of incurable cachectic cancer patients on home parenteral nutrition: a multi-centre observational study with prospective follow-up of 414 patients. Ann Oncol 25 (2014), 487–493.
191. Brennan, M.F., Pisters, P.W., Posner, M., Quesada, O., Shike, M., A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy. Ann Surg 220 (1994), 436–441 discussion 441–4.
192. Scolapio, J.S., Ukleja, A., Burnes, J.U., Kelly, D.G., Outcome of patients with radiation enteritis treated with home parenteral nutrition. Am J Gastroenterol 97 (2002), 662–666.
193. Klein, S., Koretz, R.L., Nutrition support in patients with cancer: what do the data really show?. Nutr Clin Pract 9 (1994), 91–100.
194. Staun, M., Hebuterne, X., Shaffer, J., Haderslev, K.V., Bozzetti, F., Pertkiewicz, M., et al. Management of intestinal failure in Europe. A questionnaire based study on the incidence and management. Dyn Med 4 (2007), 6–7.
195. Shaw, S.A., Rühlin, M., Wagener, N., Stanga, Z., Meier, R., Ballmer, P.E., Home artificial nutrition in Switzerland: an epidemiological survey from 2005 to 2009. Ann Nutr Metab 62 (2013), 207–213.
196. Cotogni, P., Pittiruti, M., Barbero, C., Monge, T., Palmo, A., Boggio Bertinet, D., Catheter-related complications in cancer patients on home parenteral nutrition: a prospective study of over 51,000 catheter days. J Parenter Enter Nutr 37 (2013), 375–383.
197. Hearing, S.D., Refeeding syndrome. BMJ 328:7445 (2004), 908–909.
198. Mehanna, H.M., Moledina, J., Travis, J., Refeeding syndrome: what it is, and how to prevent and treat it. BMJ 336:7659 (2008), 1495–1498.
199. Marinella, M.A., Refeeding syndrome: an important aspect of supportive oncology. J Support Oncol 7 (2009), 11–16.
200. Walmsley, R.S., Refeeding syndrome: screening, incidence, and treatment during parenteral nutrition. J Gastroenterol Hepatol 28:Suppl. 4 (2013), 113–117.
201. Sacks, G.S., Refeeding syndrome: awareness is the first step in preventing complications. J Support Oncol 7 (2009), 19–20.
202. Ahmed, S., Travis, J., Mehanna, H., Re-feeding syndrome in head and neck–prevention and management. Oral Oncol 47 (2011), 792–796.
203. NICE. Nutrition support for adults: oral nutritiion support, enteral tube feeding and parenteral nutrition. NICE guidelines CG32. https://www.nice.org.uk/guidance/cg32.
204. Bozzetti, F., Nutritional support of the oncology patient. Crit Rev Oncol Hematol 87:2 (2013 Aug), 172–200.
205. Ellershaw, J., Ward, C., Care of the dying patient: the last hours or days of life. BMJ 326 (2003), 30–34.
206. Druml, C., Ballmer, P.E., Druml, W., Oehmichen, F., Shenkin, A., Singer, P., et al. ESPEN guideline on ethical aspects of artificial nutrition and hydration. (in press) Clin Nutr 35 (2016), 545–556, 10.1016/j.clnu.2016.02.006.
207. Ruggeri, E., Agostini, F., Fettucciari, L., Giannantonio, M., Pironi, L., Pannuti, F., Home artificial nutrition in advanced cancer patients. Tumori 99 (2013), 218–224.
208. Orrevall, Y., Tishelman, C., Permert, J., Lundström, S., A national observational study of the prevalence and use of enteral tube feeding, parenteral nutrition and intravenous glucose in cancer patients enrolled in specialized palliative care. Nutrients 5 (2013), 267–282.
209. Fan, B.G., Parenteral nutrition prolongs the survival of patients associated with malignant gastrointestinal obstruction. J Parenter Enter Nutr 31 (2007), 508–510.
210. Staun, M., Pironi, L., Bozzetti, F., Baxter, J., Forbes, A., Joly, F., et al. ESPEN guidelines on parenteral nutrition: home parenteral nutrition (HPN) in adult patients. Clin Nutr 28 (2009), 467–479.
211. Jones, L.W., Alfano, C.M., Exercise-oncology research: past, present, and future. Acta Oncol Stockh Swed 52 (2013), 195–215.
212. Oldervoll, L.M., Loge, J.H., Lydersen, S., Paltiel, H., Asp, M.B., Nygaard, U.V., et al. Physical exercise for cancer patients with advanced disease: a randomized controlled trial. Oncol 16 (2011), 1649–1657.
213. Lowe, S.S., Watanabe, S.M., Courneya, K.S., Physical activity as a supportive care intervention in palliative cancer patients: a systematic review. J Support Oncol 7 (2009), 27–34.
214. Speck, R.M., Courneya, K.S., Masse, L.C., Duval, S., Schmitz, K.H., An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J cancer Surviv Res Pract 4 (2010), 87–100.
215. Stene, G.B., Helbostad, J.L., Balstad, T.R., Riphagen II, Kaasa, S., Oldervoll, L.M., Effect of physical exercise on muscle mass and strength in cancer patients during treatment–a systematic review. Crit Rev Oncol/Hematol 88 (2013), 573–593.
216. Fong, D.Y., Ho, J.W., Hui, B.P., Lee, A.M., Macfarlane, D.J., Leung, S.S., et al. Physical activity for cancer survivors: meta-analysis of randomised controlled trials. BMJ, 344, 2012, e70.
217. Awad, S., Tan, B.H., Cui, H., Bhalla, A., Fearon, K.C., Parsons, S.L., et al. Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin Nutr 31 (2012), 74–77.
218. Antoun, S., Birdsell, L., Sawyer, M.B., Venner, P., Escudier, B., Baracos, V.E., Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled study. J Clin Oncol 28 (2010), 1054–1060.
219. Ferriolli, E., Physical activity monitoring: a responsive and meaningful patient-centered outcome for surgery, chemotherapy, or radiotherapy?. J Pain Symptom Manage 43 (2012), 1025–1035.
220. Kortebein, P., Ferrando, A., Lombeida, J., Wolfe, R., Evans, W.J., Effect of 10 days of bed rest on skeletal muscle in healthy older adults. JAMA 297 (2007), 1772–1774.
221. Yavuzsen, T., Davis, M.P., Walsh, D., LeGrand, S., Lagman, R., Systematic review of the treatment of cancer-associated anorexia and weight loss. J Clin Oncol 23 (2005), 8500–8511.
222. Paulsen, O., Klepstad, P., Rosland, J.H., Aass, N., Albert, E., Fayers, P., et al. Efficacy of methylprednisolone on pain, fatigue, and appetite loss in patients with advanced cancer using opioids: a randomized, placebo-controlled, double-blind trial. J Clin Oncol 32 (2014), 3221–3228.
223. Miller, S., McNutt, L., McCann, M.A., McCorry, N., Use of corticosteroids for anorexia in palliative medicine: a systematic review. J Palliat Med 17 (2014), 482–485.
224. Moertel, C.G., Schutt, A.J., Reitemeier, R.J., Hanh, R.G., Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer 33 (1974), 1607–1609.
225. Maltoni, M., Nanni, O., Scarpi, E., Rossi, D., Serra, P., Amadori, D., High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials. Ann Oncol 12 (2001), 289–300.
226. Lesniak, W., Bala, M., Jaeschke, R., Krzakowski, M., Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome–a systematic review and meta-analysis. Pol Arch Med Wewnętrznej 118 (2008), 636–644.
227. Ruiz Garcia, V., López-Briz, E., Carbonell Sanchis, R., Gonzalvez Perales, J.L., Bort-Marti, S., Megestrol acetate for treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev, 28(3), 2013, CD004310.
228. Lambert, D.M., Fowler, C.J., The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. J Med Chem 48 (2005), 5059–5087.
229. Pacher, P., Bátkai, S., Kunos, G., The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58 (2006), 389–462.
230. Nelson, K., Walsh, D., Deeter, P., Sheehan, F., A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia. J Palliat Care 10 (1994), 14–18.
231. Cannabis-In-Cachexia-Study-Group, Strasser, F., Luftner, D., Possinger, K., Ernst, G., Ruhstaller, T., et al. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. J Clin Oncol 24 (2006), 3394–3400.
232. Jatoi, A., Windschitl, H.E., Loprinzi, C.L., Sloan, J.A., Dakhil, S.R., Mailliard, J.A., et al. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol 20 (2002), 567–573.
233. Brisbois, T.D., de Kock, I.H., Watanabe, S.M., Mirhosseini, M., Lamoureux, D.C., Chasen, M., et al. Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. Ann Oncol 22 (2011), 2086–2093.
234. Epstein, J.B., Barasch, A., Taste disorders in cancer patients: pathogenesis, and approach to assessment and management. Oral Oncol 46 (2010), 77–81.
235. Ripamonti, C., Zecca, E., Brunelli, C., Fulfaro, F., Villa, S., Balzarini, A., et al. A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation. Cancer 82 (1998), 1938–1945.
236. Lyckholm, L., Heddinger, S.P., Parker, G., Coyne, P.J., Ramakrishnan, V., Smith, T.J., et al. A randomized, placebo controlled trial of oral zinc for chemotherapy-related taste and smell disorders. J Pain Palliat Care Pharmacother 26 (2012), 111–114.
237. Strasser, F., Lutz, T.A., Maeder, M.T., Thuerlimann, B., Bueche, D., Tschöp, M., et al. Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study. Br J Cancer 98 (2008), 300–308.
238. Lundholm, K., Gunnebo, L., Körner, U., Iresjö, B.M., Engström, C., Hyltander, A., et al. Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients: a randomized double-blind study. Cancer 116 (2010), 2044–2052.
239. Adachi, S., Takiguchi, S., Okada, K., Yamamoto, K., Yamasaki, M., Miyata, H., et al. Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study. Gastroenterology 138 (2010), 1312–1320.
240. Temel, J., Abernethy, A.P., Currow, D.C., Friend, J., Duus, E.M., Yan, Y., et al. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol, 2016, 10.1016/S1470-2045(15)00558-6.
241. Sinha-Hikim, I., Taylor, W.E., Gonzalez-Cadavid, N.F., Zheng, W., Bhasin, S., Androgen receptor in human skeletal muscle and cultured muscle satellite cells: up-regulation by androgen treatment. J Clin Endocrinol Metab 89 (2004), 5245–5255.
242. Burney, B.O., Hayes, T.G., Smiechowska, J., Cardwell, G., Papusha, V., Bhargava, P., et al. Low testosterone levels and increased inflammatory markers in patients with cancer and relationship with cachexia. J Clin Endocrinol Metab 97 (2012), E700–E709.
243. Chlebowski, R.T., Herrold, J., Ali, I., Oktay, E., Chlebowski, J.S., Ponce, A.T., et al. Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer. Cancer 58 (1986), 183–186.
244. Loprinzi, C.L., Kugler, J.W., Sloan, J.A., Mailliard, J.A., Krook, J.E., Wilwerding, M.B., et al. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. J Clin Oncol 17 (1999), 3299–3306.
245. Dobs, A.S., Boccia, R.V., Croot, C.C., Gabrail, N.Y., Dalton, J.T., Hancock, M.L., et al. Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial. Lancet Oncol 14 (2013), 335–345.
246. Lundholm, K., Körner, U., Gunnebo, L., Sixt-Ammilon, P., Fouladiun, M., Daneryd, P., et al. Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning. Clin Cancer Res 13 (2007), 2699–2706.
247. Slater, G.J., Jenkins, D., Beta-hydroxy-bety-methylbutyrate (HMB) supplementation and the promotion of muscle growth and strength. Sports Med 30 (2000), 105–116.
248. May, P.E., Barber, A., D'Olimpio, J.T., Hourihane, A., Abumrad, N.N., Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine. Am J Surg 183 (2002), 471–479.
249. Berk, L., James, J., Schwartz, A., Hug, E., Mahadevan, A., Samuels, M., et al. A randomized, double-blind, placebo-controlled trial of a beta-hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122). Support Care Cancer 16 (2008), 1179–1188.
250. Alpers, D.H., Glutamine: do the data support the cause for glutamine supplementation in humans?. Gastroenterology 130 (2006), S106–S116.
251. DeBerardinis, R.J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci U. S. A 104 (2007), 19345–19350.
252. Huang, W., Choi, W., A proposed role for glutamine in cancer cell growth through acid resistance. Cell Res 23 (2013), 724–727.
253. Holecek, M., Side effects of long-term glutamine supplementation. J Parenter Enter Nutr 37 (2013), 607–616.
254. McMillan, D.C., Wigmore, S.J., Fearon, K.C., O'Gorman, P., Wright, C.E., McArdle, C.S., A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss. Br J Cancer 79 (1999), 495–500.
255. Lai, V., George, J., Richey, L., Kim, H.J., Cannon, T., Shores, C., et al. Results of a pilot study of the effects of celecoxib on cancer cachexia in patients with cancer of the head, neck, and gastrointestinal tract. Head Neck 30 (2008), 67–74.
256. Madeddu, C., Dessì, M., Panzone, F., Serpe, R., Antoni, G., Cau, M.C., et al. Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome. Clin Nutr 31 (2012), 176–182.
257. Goldberg, R.M., Loprinzi, C.L., Mailliard, J.A., O'Fallon, J.R., Krook, J.E., Ghosh, C., et al. Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial. J Clin Oncol 13 (1995), 2856–2859.
258. Del Fabbro, E., Dev, R., Hui, D., Palmer, L., Bruera, E., Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial. J Clin Oncol 31 (2013), 1271–1276.
259. Jatoi, A., Ritter, H.L., Dueck, A., Nguyen, P.L., Nikcevich, D.A., Luyun, R.F., et al. A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9). Lung Cancer 68 (2010), 234–239.
260. Reid, J., Mills, M., Cantwell, M., Cardwell, C.R., Murray, L.J., Donnelly, M., Thalidomide for managing cancer cachexia. Cochrane Database Syst Rev, 4, 2012, CD008664.
261. Gordon, J.N., Trebble, T.M., Ellis, R.D., Duncan, H.D., Johns, T., Goggin, P.M., Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial. Gut 54 (2005), 540–545.
262. Yennurajalingam, S., Willey, J.S., Palmer, J.L., Allo, J., Del Fabbro, E., Cohen, E.N., et al. The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study. J Palliat Med 15 (2012), 1059–1064.
263. Mantovani, G., Macciò, A., Madeddu, C., Serpe, R., Massa, E., Dessì, M., et al. Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia. Oncol 15 (2010), 200–211.
264. Wilkes, E.A., Selby, A.L., Cole, A.T., Freeman, J.G., Rennie, M.J., Khan, Z.H., Poor tolerability of thalidomide in end-stage oesophageal cancer. Eur J Cancer Care Engl 20 (2011), 593–600.
265. Ando, K., Takahashi, F., Motojima, S., Nakashima, K., Kaneko, N., Hoshi, K., Takahashi K.Possible role for tocilizumab, an anti-interleukin-6 receptor antibody, in treating cancer cachexia. J Clin Oncol 31 (2013), e69–72.
266. Hirata, H., Tetsumoto, S., Kijima, T., Kida, H., Kumagai, T., Takahashi, R., et al. Favorable responses to tocilizumab in two patients with cancer-related cachexia. J Pain Symptom Manage 46 (2013), e9–e13.
267. Bayliss, T.J., Smith, J.T., Schuster, M., Dragnev, K.H., Rigas, J.R., A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer. Expert Opin Biol Ther 11 (2011), 1663–1668.
268. Solheim, T.S., Fearon, K.C., Blum, D., Kaasa, S., Non-steroidal anti-inflammatory treatment in cancer cachexia: a systematic literature review. Acta Oncol 52 (2013), 6–17.
269. Faber, J., Berkhout, M., Fiedler, U., Avlar, M., Witteman, B.J., Vos, A.P., et al. Rapid EPA and DHA incorporation and reduced PGE2 levels after one week intervention with a medical food in cancer patients receiving radiotherapy, a randomized trial. Clin Nutr 32 (2013), 338–345.
270. Wigmore, S.J., Fearon, K.C., Maingay, J.P., Ross, J.A., Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. Clin Sci Lond 92:2 (1997 Feb), 215–221.
271. van der Meij, B.S., Langius, J.A., Smit, E.F., Spreeuwenberg, M.D., von Blomberg, B.M., Heijboer, A.C., et al. Oral nutritional supplements containing (N-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment. J Nutr 140 (2010), 1774–1780.
272. Silva, J., de, A., Trindade, E.B., Fabre, M.E., Menegotto, V.M., Gevaerd, S., Buss Zda, S., et al. Fish oil supplement alters markers of inflammatory and nutritional status in colorectal cancer patients. Nutr Cancer 64 (2012), 267–273.
273. Mocellin, M.C., Camargo, C.Q., Nunes, E.A., Fiates, G.M., Trindade, E.B., A systematic review and meta-analysis of the N-3 polyunsaturated fatty acids effects on inflammatory markers in colorectal cancer. Clin Nutr 35 (2016), 359–369.
274. Finocchiaro, C., Segre, O., Fadda, M., Monge, T., Scigliano, M., Schena, M., et al. Effect of N-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study. Br J Nutr 108 (2012), 327–333.
275. Fearon, K.C., Von Meyenfeldt, M.F., Moses, A.G., Van Geenen, R., Roy, A., Gouma, D.J., et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 52 (2003), 1479–1486.
276. van der Meij, B.S., Langius, J.A., Spreeuwenberg, M.D., Slootmaker, S.M., Paul, M.A., Smit, E.F., et al. Oral nutritional supplements containing N-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT. Eur J Clin Nutr 66 (2012), 399–404.
277. Murphy, R.A., Mourtzakis, M., Chu, Q.S., Baracos, V.E., Reiman, T., Mazurak, V.C., Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy. Cancer 117 (2011), 1775–1782.
278. Trabal, J., Leyes, P., Forga, M., Maurel, J., Potential usefulness of an EPA-enriched nutritional supplement on chemotherapy tolerability in cancer patients without overt malnutrition. Nutr Hosp 25 (2010), 736–740.
279. Sánchez-Lara, K., Turcott, J.G., Juárez-Hernández, E., Nuñez-Valencia, C., Villanueva, G., Guevara, P., et al. Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised trial. Clin Nutr 33 (2014), 1017–1023.
280. Murphy, R.A., Mourtzakis, M., Chu, Q.S., Baracos, V.E., Reiman, T., Mazurak, V.C., Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer. Cancer 117 (2011), 3774–3780.
281. Gogos, C.A., Ginopoulos, P., Salsa, B., Apostolidou, E., Zoumbos, N.C., Kalfarentzos, F., Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer 82 (1998), 395–402.
282. Bruera, E., Strasser, F., Palmer, J.L., Willey, J., Calder, K., Amyotte, G., et al. Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. J Clin Oncol 21 (2003), 129–134.
283. Jatoi, A., Rowland, K., Loprinzi, C.L., Sloan, J.A., Dakhil, S.R., MacDonald, N., et al., North Central Cancer Treatment Group. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol 22 (2004), 2469–2476.
284. Fearon, K.C., Barber, M.D., Moses, A.G., Ahmedzai, S.H., Taylor, G.S., Tisdale, M.J., et al. Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. J Clin Oncol 24 (2006), 3401–3407.
285. Dewey, A., Baughan, C., Dean, T., Higgins, B., Johnson, I., Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane Database Syst Rev, 1, 2007 Jan 24, CD004597.
286. Mazzotta, P., Jeney, C.M., Anorexia-cachexia syndrome: a systematic review of the role of dietary polyunsaturated fatty acids in the management of symptoms, survival, and quality of life. J Pain Symptom Manage 37 (2009), 1069–1077.
287. Ries, A., Trottenberg, P., Elsner, F., Stiel, S., Haugen, D., Kaasa, S., et al. A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: an EPCRC cachexia guidelines project. Palliat Med 26 (2012), 294–304.
288. Colomer, R., Moreno-Nogueira, J.M., García-Luna, P.P., García-Peris, P., García-de-Lorenzo, A., Zarazaga, A., et al. N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr 97 (2007), 823–831.
289. de Aguiar Pastore Silva, J., Emilia de Souza, Fabre M., Waitzberg, D.L., Omega-3 supplements for patients in chemotherapy and/or radiotherapy: a systematic review. Clin Nutr 34 (2015), 359–366.
290. Clarke, J.T., Cullen-Dean, G., Regelink, E., Chan, L., Rose, V., Increased incidence of epistaxis in adolescents with familial hypercholesterolemia treated with fish oil. J Pediatr 116 (1990), 139–141.
291. EFSA Panel on Dietetic Products, Nutrition and Allergy (NDA). Scientific opinion on the tolerable upper intake level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DH) and docosapentaenoic acid (DPA). EFSA J, 10(7), 2012, 2815.
292. Pardini, R.S., Nutritional intervention with omega-3 fatty acids enhances tumor response to anti-neoplastic agents. Chem Biol Interact 162 (2006), 89–105.
293. Hardman, W.E., N-3 fatty acids and cancer therapy. J Nutr 134:12 Suppl. (2004 Dec), 3427S–3430S.
294. Serafini, P., Editorial: PGE2-producing MDSC: a role in tumor progression?. J Leukoc Biol 88 (2010), 827–829.
295. Haqq, J., Howells, L.M., Garcea, G., Dennison, A.R., Targeting pancreatic cancer using a combination of gemcitabine with the omega-3 polyunsaturated fatty acid emulsion. Lipidem™ Mol Nutr Food Res, 2015, 10.1002/mnfr.201500755.
296. Roodhart, J.M., Daenen, L.G., Stigter, E.C., Prins, H.J., Gerrits, J., Houthuijzen, J.M., et al. Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids. Cancer Cell 20 (2011), 370–383.
297. Daenen, L.G., Cirkel, G.A., Houthuijzen, J.M., Gerrits, J., Oosterom, I., Roodhart, J.M., et al. Increased plasma levels of chemoresistance-inducing fatty acid 16:4(N-3) after consumption of fish and fish oil. JAMA Oncol 1 (2015), 350–358.
298. Murphy, R.A., Clandinin, M.T., Chu, Q.S., Arends, J., Mazurak, V.C., A fishy conclusion regarding N-3 fatty acid supplementation in cancer patients. Clin Nutr 32 (2013), 466–467.
299. Bougnoux, P., Hajjaji, N., Ferrasson, M.N., Giraudeau, B., Couet, C., Le Floch, O., Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial. Br J Cancer 101 (2009), 1978–1985.
300. Michael-Titus, A.T., Priestley, J.V., Omega-3 fatty acids and traumatic neurological injury: from neuroprotection to neuroplasticity?. Trends Neurosci 37 (2014), 30–38.
301. Coste, T.C., Gerbi, A., Vague, P., Pieroni, G., Raccah, D., Neuroprotective effect of docosahexaenoic acid-enriched phospholipids in experimental diabetic neuropathy. Diabetes 52 (2003), 2578–2585.
302. Ghoreishi, Z., Esfahani, A., Djazayeri, A., Djalali, M., Golestan, B., Ayromlou, H., et al. Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial. BMC Cancer, 12, 2012, 355.
303. Elbarbary, N.S., Ismail, E.A., Farahat, R.K., El-Hamamsy, M., ω-3 fatty acids as an adjuvant therapy ameliorates methotrexate-induced hepatotoxicity in children and adolescents with acute lymphoblastic leukemia: a randomized placebo-controlled study. Nutrition 32 (2016), 41–47.
304. Hiyama, T., Yoshihara, M., Tanaka, S., Haruma, K., Chayama, K., Effectiveness of prokinetic agents against diseases external to the gastrointestinal tract. J Gastroenterol Hepatol 24 (2009), 537–546.
305. Bruera, E.D., MacEachern, T.J., Spachynski, K.A., LeGatt, D.F., MacDonald, R.N., Babul, N., et al. Comparison of the efficacy, safety, and pharmacokinetics of controlled release and immediate release metoclopramide for the management of chronic nausea in patients with advanced cancer. Cancer 74 (1994), 3204–3211.
306. Bruera, E., Belzile, M., Neumann, C., Harsanyi, Z., Babul, N., Darke, A., A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. J Pain Symptom Manage 19 (2000), 427–435.
307. Russell, D.M., Freedman, M.L., Feiglin, D.H., Jeejeebhoy, K.N., Swinson, R.P., Garfinkel, P.E., Delayed gastric emptying and improvement with domperidone in a patient with anorexia nervosa. Am J Psychiatry 140 (1983), 1235–1236.
308. Stacher, G., Kiss, A., Wiesnagrotzki, S., Bergmann, H., Höbart, J., Schneider, C., Oesophageal and gastric motility disorders in patients categorised as having primary anorexia nervosa. Gut 27 (1986), 1120–1126.
309. Chial, H.J., McAlpine, D.E., Camilleri, M., Anorexia nervosa: manifestations and management for the gastroenterologist. Am J Gastroenterol 97 (2002), 255–269.
310. Cadario, B.J., Leathem, A.M., (eds.) Drug information reference, 5th ed., 2003, BC Drug and Poison Information Centre, Vancouver, 462–463.
311. Raedsch, R., Hanisch, J., Bock, P., Sibaev, A., Vinson, B., Gundermann, K.J., Assessment of the efficacy and safety of the phytopharmacon STW5 versus metoclopramide in functional dyspepsia – a retrolective cohort study. Z Gastroenterol 45 (2007), 1041–1048.
312. Wlock, K., Domperidone – keeping abreast of the controversies. Brit Columbia Pharm Assoc Tablet 15 (2006), 5–6.
313. ®) society recommendations. Clin Nutr 31 (2012), 783–800.
314. Fearon, K.C., Ljungqvist, O., Von Meyenfeldt, M., Revhaug, A., Dejong, C.H., Lassen, K., et al. Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing colonic resection. Clin Nutr 24 (2005), 466–477.
315. Gustafsson, U.O., Ljungqvist, O., Perioperative nutritional management in digestive tract surgery. Curr Opin Clin Nutr Metab Care 14 (2011), 504–509.
316. Ljungqvist, O., Jonathan E. Rhoads lecture 2011: insulin resistance and enhanced recovery after surgery. J Parenter Enter Nutr 36 (2012), 389–398.
317. Hendry, P.O., Hausel, J., Nygren, J., Lassen, K., Dejong, C.H., Ljungqvist, O., et al., Enhanced Recovery After Surgery Study Group. Determinants of outcome after colorectal resection within an enhanced recovery programme. Br J Surg 96 (2009), 197–205.
318. Beattie, A.H., Prach, A.T., Baxter, J.P., Pennington, C.R., A randomised controlled trial evaluating the use of enteral nutritional supplements postoperatively in malnourished surgical patients. Gut 46 (2000), 813–818.
319. ®) society recommendations. Br J Surg 101 (2014), 1209–1229.
320. Tyldesley, S., Sheehan, F., Munk, P., Tsang, V., Skarsgard, D., Bowman, C.A., et al. Prediction of operative morbidity and mortality by preoperative nutritional assessment. Surg Forum 30 (1979), 80–82.
321. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group, Perioperative total parenteral nutrition in surgical patients. N Engl J Med 325 (1991), 525–532.
322. Marimuthu, K., Varadhan, K.K., Ljungqvist, O., Lobo, D.N., A meta-analysis of the effect of combinations of immune modulating nutrients on outcome in patients undergoing major open gastrointestinal surgery. Ann Surg 255 (2012), 1060–1068.
323. Odelli, C., Burgess, D., Bateman, L., Hughes, A., Ackland, S., Gillies, J., et al. Nutrition support improves patient outcomes, treatment tolerance and admission characteristics in oesophageal cancer. Clin Oncol R Coll Radiol 17 (2005), 639–645.
324. van den Berg, M.G., Rasmussen-Conrad, E.L., Wei, K.H., Lintz-Luidens, H., Kaanders, J.H., Merkx, M.A., Comparison of the effect of individual dietary counselling and of standard nutritional care on weight loss in patients with head and neck cancer undergoing radiotherapy. Br J Nutr 104 (2010), 872–877.
325. Thiel, H.J., Fietkau, R., Sauer, R., Malnutrition and the role of nutritional support for radiation therapy patients. Recent Results Cancer Res 108 (1988), 205–226.
326. Nayel, H., el-Ghoneimy, E., el-Haddad, S., Impact of nutritional supplementation on treatment delay and morbidity in patients with head and neck tumors treated with irradiation. Nutrition 8 (1992), 13–18.
327. Paccagnella, A., Morello, M., Da Mosto, M.C., Baruffi, C., Marcon, M.L., Gava, Ae, et al. Early nutritional intervention improves treatment tolerance and outcomes in head and neck cancer patients undergoing concurrent chemoradiotherapy. Support Care Cancer 18 (2010), 837–845.
328. Nugent, B., Lewis, S., O'Sullivan, J.M., Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy. Cochrane Database Syst Rev, 1, 2013 Jan 31, CD007904.
329. Fietkau, R., Iro, H., Sailer, D., Sauer, R., Percutaneous endoscopically guided gastrostomy in patients with head and neck cancer. Recent Results Cancer Res 121 (1991), 269–282.
330. Tyldesley, S., Sheehan, F., Munk, P., Tsang, V., Skarsgard, D., Bowman, C.A., et al. The use of radiologically placed gastrostomy tubes in head and neck cancer patients receiving radiotherapy. Int J Radiat Oncol Biol Phys 36 (1996), 1205–1209.
331. Bozzetti, F., Cozzaglio, L., Gavazzi, C., Bidoli, P., Bonfanti, G., Montalto, F., et al. Nutritional support in patients with cancer of the esophagus: impact on nutritional status, patient compliance to therapy, and survival. Tumori 84 (1998), 681–686.
332. Lee, J.H., Machtay, M., Unger, L.D., Weinstein, G.S., Weber, R.S., Chalian, A.A., et al. Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck. Arch Otolaryngol Head Neck Surg 124:8 (1998), 871–875.
333. van den Berg, M.G., Rasmussen-Conrad, E.L., van Nispen, L., van Binsbergen, J.J., Merkx, M.A., A prospective study on malnutrition and quality of life in patients with head and neck cancer. Oral Oncol 44 (2008), 830–837.
334. Isenring, E.A., Capra, S., Bauer, J.D., Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area. Br J Cancer 91 (2004), 447–452.
335. Khalid, U., McGough, C., Hackett, C., Blake, P., Harrington, K.J., Khoo, V.S., et al. A modified inflammatory bowel disease questionnaire and the Vaizey Incontinence questionnaire are more sensitive measures of acute gastrointestinal toxicity during pelvic radiotherapy than RTOG grading. Int J Radiat Oncol Biol Phys 64 (2006), 1432–1441.
336. Isenring, E.A., Bauer, J.D., Capra, S., Nutrition support using the American Dietetic Association medical nutrition therapy protocol for radiation oncology patients improves dietary intake compared with standard practice. J Am Diet Assoc 107 (2007), 404–412.
337. Elia, M., Van Bokhorst-de van der Schueren, M.A., Garvey, J., Goedhart, A., Lundholm, K., Nitenberg, G., et al. Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review. Int J Oncol 28 (2006), 5–23.
338. Cereda, E., Cappello, S., Caccialanza, R., The use of oral nutritional supplements in patients with head and neck cancer receiving (chemo)radiotherapy. Clin Nutr, 33, 2014, 370.
339. http://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/head-neck.
340. Head and Neck Guideline Steering Committee. Evidence-based practice guidelines for the nutritional management of adult patients with head and neck cancer. Sydney: Cancer Council Australia. [Version URL: http://wiki.cancer.org.au/australiawiki/index.php?oldid=116710, cited 2016 Apr 18]. Available from: http://wiki.cancer.org.au/australia/COSA: Head_and_neck_cancer_nutrition_guidelines.
341. Marcy, P.Y., Magné, N., Bensadoun, R.J., Bleuse, A., Falewee, M.N., Viot, M., et al. Systematic percutaneous fluoroscopic gastrostomy for concomitant radiochemotherapy of advanced head and neck cancer: optimization of therapy. Support Care Cancer 8 (2000), 410–413.
342. Rabinovitch, R., Grant, B., Berkey, B.A., Raben, D., Ang, K.K., Fu, K.K., et al., Radiation Therapy Oncology Group. Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03. Head Neck 28 (2006), 287–296.
343. Lewis, S.L., Brody, R., Touger-Decker, R., Parrott, J.S., Epstein, J., Feeding tube use in patients with head and neck cancer. Head Neck 36 (2014), 1789–1795.
344. Trotti, A., Bellm, L.A., Epstein, J.B., Frame, D., Fuchs, H.J., Gwede, C.K., et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66 (2003), 253–262.
345. Campos, A.C., Butters, M., Meguid, M.M., Home enteral nutrition via gastrostomy in advanced head and neck cancer patients. Head Neck 12 (1990), 137–142.
346. Mekhail, T.M., Adelstein, D.J., Rybicki, L.A., Larto, M.A., Saxton, J.P., Lavertu, P., et al. Enteral nutrition during treatment of head and neck carcinoma. Cancer 91 (2001), 1785–1790.
347. Daly, J.M., Hearne, B., Dunaj, J., LePorte, B., Vikram, B., Strong, E., et al. Nutritional rehabilitation in patients with advanced head and neck cancer receiving radiation therapy. Am J Surg 148 (1984), 514–520.
348. Cannaby, A.M., Evans, L., Freeman, A., Nursing care of patients with nasogastric feeding tubes. Br J Nurs 11 (2002), 366–372.
349. Burkitt, P., Carter, L.M., Smith, A.B., Kanatas, A., Outcomes of percutaneous endoscopic gastrostomy and radiologically inserted gastrostomy in patienst with head and neck cancer: a systematic review. Br J Oral Maxillofac Surg 49 (2011), 516–520.
350. Paleri, V., Roe, J.W., Strojan, P., Corry, J., Grégoire, V., Hamoir, M., et al. Strategies to reduce long-term postchemoradiation dysphagia in patients with head and neck cancer: an evidence-based review. Head Neck 36 (2014), 431–443.
351. Wang, J., Liu, M., Liu, C., Ye, Y., Huang, G., Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for patients with head and neck cancer: a systematic review. J Radiat Res 22 (2014), 1–9.
352. Gomes, C.A. Jr., Andriolo, R.B., Bennett, C., Lustosa, S.A., Matos, D., Waisberg, D.R., et al. Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances. Cochrane Database Syst Rev, 3, 2015, CD008096.
353. Lees, J., Nasogastric and percutaneous endoscopic gastrostomy feeding in head and neck cancer patients receiving radiotherapy treatment at a regional oncology unit: a two year study. Eur J Cancer Care Engl 6 (1997), 45–49.
354. Fietkau, R., Lewitzki, V., Kuhnt, T., Hölscher, T., Hess, C.F., Berger, B., et al. A disease-specific enteral nutrition formula improves nutritional status and functional performance in patients with head and neck and esophageal cancer undergoing chemoradiotherapy: results of a randomized, controlled, multicenter trial. Cancer 119 (2013), 3343–3353.
355. Schindler, A., Denaro, N., Russi, E.G., Pizzorni, N., Bossi, P., Merlotti, A., et al. Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: literature review and consensus. Crit Rev Oncol Hematol 96 (2015), 372–384.
356. Nguyen, N.P., Moltz, C.C., Frank, C., Vos, P., Smith, H.J., Karlsson, U., et al. Evolution of chronic dysphagia following treatment for head and neck cancer. Oral Oncol 42 (2006), 374–380.
357. Savarese, D.M., Savy, G., Vahdat, L., Wischmeyer, P.E., Corey, B., Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treat Rev 29 (2003), 501–513.
358. Kozelsky, T.F., Meyers, G.E., Sloan, J.A., Shanahan, T.G., Dick, S.J., Moore, R.L., et al., North Central Cancer Treatment Group. Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy. J Clin Oncol 21 (2003), 1669–1674.
359. Rotovnik Kozjek, N., Kompan, L., Soeters, P., Oblak, I., Mlakar Mastnak, D., Možina, B., et al. Oral glutamine supplementation during preoperative radiochemotherapy in patients with rectal cancer: a randomised double blinded, placebo controlled pilot study. Clin Nutr 30 (2011), 567–570.
360. Vidal-Casariego, A., Calleja-Fernández, A., de Urbina-González, J.J., Cano-Rodríguez, I., Cordido, F., Ballesteros-Pomar, M.D., Efficacy of glutamine in the prevention of acute radiation enteritis: a randomized controlled trial. J Parenter Enter Nutr 38 (2014), 205–213.
361. Kucuktulu, E., Guner, A., Kahraman, I., Topbas, M., Kucuktulu, U., The protective effects of glutamine on radiation-induced diarrhea. Support Care Cancer 21 (2013), 1071–1075.
362. Huang, E.Y., Leung, S.W., Wang, C.J., Chen, H.C., Sun, L.M., Fang, F.M., et al. Oral glutamine to alleviate radiation-induced oral mucositis: a pilot randomized trial. Int J Radiat Oncol Biol Phys 46 (2000), 535–539.
363. Cerchietti, L.C., Navigante, A.H., Lutteral, M.A., Castro, M.A., Kirchuk, R., Bonomi, M., et al. Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 65 (2006), 1330–1337.
364. Tsujimoto, T., Yamamoto, Y., Wasa, M., Takenaka, Y., Nakahara, S., Takagi, T., et al. L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial. Oncol Rep 33 (2015), 33–39.
365. Coghlin Dickson, T.M., Wong, R.M., offrin, R.S., Shizuru, J.A., Johnston, L.J., Hu, W.W., et al. Effect of oral glutamine supplementation during bone marrow transplantation. J Parenter Enter Nutr 24 (2000), 61–66.
366. Topkan, E., Parlak, C., Topuk, S., Pehlivan, B., Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer. BMC Cancer, 12, 2012, 502.
367. Rubio, I., Suva, L.J., Todorova, V., Bhattacharyya, S., Kaufmann, Y., Maners, A., et al. Oral glutamine reduces radiation morbidity in breast conservation surgery. J Parenter Enter Nutr 37 (2013), 623–630.
368. Eda, K., Uzer, K., Murat, T., Cenk, U., The effects of enteral glutamine on radiotherapy induced dermatitis in breast cancer. Clin Nutr 35 (2016), 436–439.
369. Pytlík, R., Benes, P., Patorková, M., Chocenská, E., Gregora, E., Procházka, B., et al. Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind, placebo controlled study. Bone Marrow Transpl 30 (2002), 953–961.
370. Crowther, M., Avenell, A., Culligan, D.J., Systematic review and meta-analyses of studies of glutamine supplementation in haematopoietic stem cell transplantation. Bone Marrow Transpl 44 (2009), 413–425.
371. Andreyev, H.J., Wotherspoon, A., Denham, J.W., Hauer-Jensen, M., “Pelvic radiation disease”: new understanding and new solutions for a new disease in the era of cancer survivorship. Scand J Gastroenterol 46 (2011), 389–397.
372. Andreyev, H.J., Gastrointestinal problems after pelvic radiotherapy: the past, the present and the future. Clin Oncol R Coll Radiol 19 (2007), 790–799.
373. Demers, M., Dagnault, A., Desjardins, J., A randomized double-blind controlled trial: impact of probiotics on diarrhea in patients treated with pelvic radiation. Clin Nutr 33 (2014), 761–767.
374. Salminen, E., Elomaa, I., Minkkinen, J., Vapaatalo, H., Salminen, S., Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures. Clin Radiol 39 (1988), 435–437.
375. Urbancsek, H., Kazar, T., Mezes, I., Neumann, K., Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhoea. Eur J Gastroenterol Hepatol 13 (2001), 391–396.
376. Delia, P., Sansotta, G., Donato, V., Frosina, P., Messina, G., De Renzis, C., et al. Use of probiotics for prevention of radiation-induced diarrhea. World J Gastroenterol 13 (2007), 912–915.
377. Giralt, J., Regadera, J.P., Verges, R., Romero, J., de la Fuente, I., Biete, A., et al. Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiation-induced diarrhea: results from multicenter, randomized, placebo-controlled nutritional trial. Int J Radiat Oncol Biol Phys 71 (2008), 1213–1219.
378. Chitapanarux, I., Chitapanarux, T., Traisathit, P., Kudumpee, S., Tharavichitkul, E., Lorvidhaya, V., Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat Oncol, 5, 2010, 31.
379. Wedlake, L.J., Shaw, C., Whelan, K., Andreyev, H.J., Systematic review: the efficacy of nutritional interventions to counteract acute gastrointestinal toxicity during therapeutic pelvic radiotherapy. Aliment Pharmacol Ther 37 (2013), 1046–1056.
380. Gibson, R.J., Keefe, D.M., Lalla, R.V., Bateman, E., Blijlevens, N., Fijlstra, M., et al. Systematic review of agents for the management of gastrointestinal mucositis in cancer patients. Support Care Cancer 21 (2014), 313–326.
381. Hamad, A., Fragkos, K.C., Forbes, A., A systematic review and meta-analysis of probiotics for the management of radiation induced bowel disease. Clin Nutr 32 (2013), 353–360.
382. Henson, C.C., Burden, S., Davidson, S.E., Lal, S., Nutritional interventions for reducing gastrointestinal toxicity in adults undergoing radical pelvic radiotherapy. Cochrane Database Syst Rev, 11, 2013, CD009896.
383. Theis, V.S., Sripadam, R., Ramani, V., Lal, S., Chronic radiation enteritis. Clin Oncol R Coll Radiol 22 (2010), 70–83.
384. Gavazzi, C., Bhoori, S., Lovullo, S., Cozzi, G., Mariani, L., Role of home parenteral nutrition in chronic radiation enteritis. Am J Gastroenterol 101 (2006), 374–379.
385. Kalaiselvan, R., Theis, V.S., Dibb, M., Teubner, A., Anderson, I.D., Shaffer, J.L., et al. Radiation enteritis leading to intestinal failure: 1994 patient-years of experience in a national referral centre. Eur J Clin Nutr 68 (2014), 166–170.
386. Prado, C.M., Baracos, V.E., McCargar, L.J., Mourtzakis, M., Mulder, K.E., Reiman, T., et al. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res 13 (2007), 3264–3268.
387. Dy, G.K., Adjei, A.A., Understanding, recognizing, and managing toxicities of targeted anticancer therapies. CA Cancer J Clin 63 (2013), 249–279.
388. Massicotte, M.H., Borget, I., Broutin, S., Baracos, V.E., Leboulleux, S., Baudin, E., et al. Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study. J Clin Endocrinol Metab 98 (2013), 2401–2408.
389. Ross, P.J., Ashley, S., Norton, A., Priest, K., Waters, J.S., Eisen, T., et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?. Br J Cancer 90 (2004), 1905–1911.
390. Meuric, J., Besnard I and the working group. SFNEP Oncology nutrition guidelines: when should individualized dietetic counselling be proposed?. Nutr Clin Metab 26 (2012), 197–218.
391. Ligthart-Melis, G.C., Weijs, P.J., te Boveldt, N.D., Buskermolen, S., Earthman, C.P., Verheul, H.M., et al. Dietician-delivered intensive nutritional support is associated with a decrease in severe postoperative complications after surgery in patients with esophageal cancer. Dis Esophagus 26 (2013), 587–593.
392. Dobrila-Dintinjana, R., Trivanovic, D., Zelić, M., Radić, M., Dintinjana, M., Petranović, D., et al. Nutritional support in patients with colorectal cancer during chemotherapy: does it work?. Hepato-Gastroenterol 60 (2013), 475–480.
393. De Waele, E., Mattens, S., Honoré, P.M., Spapen, H., De Grève, J., Pen, J.J., Nutrition therapy in cachectic cancer patients. The Tight Caloric Control (TiCaCo) pilot trial. Appetite 91 (2015 Aug), 298–301.
394. Koretz, R.L., Lipman, T.O., Klein, S., AGA technical review on parenteral nutrition. Gastroenterology 121 (2001), 970–1001.
395. Miyata, H., Yano, M., Yasuda, T., Hamano, R., Yamasaki, M., Hou, E., et al. Randomized study of clinical effect of enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancer. Clin Nutr 31 (2012), 330–336.
396. Zaloga, G.P., Parenteral nutrition in adult inpatients with functioning gastrointestinal: assessment of outcomes. Lancet 367 (2006), 1101–1111.
397. Li, Y., Ping, X., Yu, B., Liu, F., Ni, X., Li, J., Clinical trial: prophylactic intravenous alanyl-glutamine reduces the severity of gastrointestinal toxicity induced by chemotherapy–a randomized crossover study. Aliment Pharmacol Ther 30 (2009), 452–458.
398. Sun, J., Wang, H., Hu, H., Glutamine for chemotherapy induced diarrhea: a meta-analysis. Asia Pac J Clin Nutr 21 (2012), 380–385.
399. Sornsuvit, C., Komindr, S., Chuncharunee, S., Wanikiat, P., Archararit, N., Santanirand, P., Pilot Study: effects of parenteral glutamine dipeptide supplementation on neutrophil functions and prevention of chemotherapy-induced side-effects in acute myeloid leukaemia patients. J Int Med Res 36 (2008), 1383–1391.
400. Sayles, C., Hickerson, S.C., Bhat, R.R., Hall, J., Garey, K.W., Trivedi, M.V., Oral glutamine in preventing treatment-related mucositis in adult patients with cancer: a systematic review. Nutr Clin Pract 31 (2016), 171–179.
401. Wang, W.S., Lin, J.K., Lin, T.C., Chen, W.S., Jiang, J.K., Wang, H.S., et al. Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients. Oncologist 12 (2007), 312–319.
402. Urbain, P., Birlinger, J., Lambert, C., Finke, J., Bertz, H., Biesalski, H.K., Longitudinal follow-up of nutritional status and its influencing factors in adults undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transpl 48 (2013), 446–451.
403. Urbain, P., Birlinger, J., Ihorst, G., Biesalski, H.K., Finke, J., Bertz, H., Body mass index and bioelectrical impedance phase angle as potentially modifiable nutritional markers are independent risk factors for outcome in allogeneic hematopoietic cell transplantation. Ann Hematol 92 (2013), 111–119.
404. Muscaritoli, M., Conversano, L., Torelli, G.F., Arcese, W., Capria, S., Cangiano, C., et al. Clinical and metabolic effects of different parenteral nutrition regimens in patients undergoing allogeneic bone marrow transplantation. Transplantation 66 (1998), 610–616.
405. Mousavi, M., Hayatshahi, A., Sarayani, A., Hadjibabaie, M., Javadi, M., Torkamandi, H., et al. Impact of clinical pharmacist-based parenteral nutrition service for bone marrow transplantation patients: a randomized clinical trial. Support Care Cancer 21 (2013), 3441–3448.
406. Morishita, S., Kaida, K., Yamauchi, S., Sota, K., Ishii, S., Ikegame, K., et al. Relationship between corticosteroid dose and declines in physical function among allogeneic hematopoietic stem cell transplantation patients. Support Care Cancer 21 (2013), 2161–2169.
407. Dimeo, F., Fetscher, S., Lange, W., Mertelsmann, R., Keul, J., Effects of aerobic exercise on the physical performance and incidence of treatment-related complications after high-dose chemotherapy. Blood 90 (1997), 3390–3394.
408. Dimeo, F.C., Tilmann, M.H., Bertz, H., Kanz, L., Mertelsmann, R., Keul, J., Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation. Cancer 79 (1997), 1717–1722.
409. Knols, R.H., de Bruin, E.D., Uebelhart, D., Aufdemkampe, G., Schanz, U., Stenner-Liewen, F., et al. Effects of an outpatient physical exercise program on hematopoietic stem-cell transplantation recipients: a randomized clinical trial. Bone Marrow Transpl 46 (2011), 1245–1255.
410. Wiskemann, J., Dreger, P., Schwerdtfeger, R., Bondong, A., Huber, G., Kleindienst, N., et al. Effects of a partly self-administered exercise program before, during, and after allogeneic stem cell transplantation. Blood 117 (2011), 2604–2613.
411. van Haren, I.E., Timmerman, H., Potting, C.M., Blijlevens, N.M., Staal, J.B., Nijhuis-van der Sanden, M.W., Physical exercise for patients undergoing hematopoietic stem cell transplantation: systematic review and meta-analyses of randomized controlled trials. Phys Ther 93 (2013), 514–528.
412. Farias, C.L., Campos, D.J., Bonfin, C.M., Vilela, R.M., Phase angle from BIA as a prognostic and nutritional status tool for children and adolescents undergoing hematopoietic stem cell transplantation. Clin Nutr 32 (2013), 420–425.
413. Kramer, M., Heussner, P., Herzberg, P.Y., Andree, H., Hilgendorf, I., Leithaeuser, M., et al. Validation of the grip test and human activity profile for evaluation of physical performance during the intermediate phase after allogeneic hematopoietic stem cell transplantation. Support Care Cancer 21 (2013), 1121–1129.
414. Seguy, D., Duhamel, A., Rejeb, M.B., Gomez, E., Buhl, N.D., Bruno, B., et al. Better outcome of patients undergoing enteral tube feeding after myeloablative conditioning for allogeneic stem cell transplantation. Transplantation 94 (2012), 287–294.
415. Guièze, R., Lemal, R., Cabrespine, A., Hermet, E., Tournilhac, O., Combal, C., et al. Enteral versus parenteral nutritional support in allogeneic haematopoietic stem-cell transplantation. Clin Nutr 33 (2014), 533–538.
416. Tavakoli-Ardakani, M., Neman, B., Mehdizadeh, M., Hajifathali, A., Salamzadeh, J., Tabarraee, M., Clinical effect of individualized parenteral nutrition vs conventional method in patients undergoing autologous hematopoietic SCT. Bone Marrow Transpl 48 (2013), 958–962.
417. Trifilio, S., Helenowski, I., Giel, M., Gobel, B., Pi, J., Greenberg, D., Mehta, J., Questioning the role of a neutropenic diet following hematopoetic stem cell transplantation. Biol Blood Marrow Transpl 18 (2012), 1385–1390.
418. Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., et al. Center for International Blood and Marrow Research National Marrow Donor program European Blood and MarrowTransplant Group American Society of Blood and Marrow Transplantation Canadian Blood and Marrow Transplant Group Infectious Diseases Society of America Society for healthcare Epidemiology of America Association of Medical microbiology and Infectious Disease Canada, Centers for Disease Control and Prevention. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transpl 15 (2009), 1143–1238.
419. van Dalen, E.C., Mank, A., Leclercq, E., Mulder, R.L., Davies, M., Kersten, M.J., et al. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia. Cochrane Database Syst Rev, 4, 2016 Apr 24, CD006247.
420. Gardner, A., Mattiuzzi, G., Faderl, S., Borthakur, G., Garcia-Manero, G., Pierce, S., et al. Randomized comparison of cooked and noncooked diets in patients undergoing remission induction therapy for acute myeloid leukemia. J Clin Oncol 26 (2008), 5684–5688.
421. Moody, K., Finlay, J., Mancuso, C., Charlson, M., Feasibility and safety of a pilot randomized trial of infection rate: neutropenic diet versus standard food safety guidelines. J Pediatr Hematol Oncol 28 (2006), 126–133.
422. Wilmore, D.W., Schloerb, P.R., Ziegler, T.R., Glutamine in the support of patients following bone marrow transplantation. Curr Opin Clin Nutr Metab Care 2 (1999), 323–327.
423. Brown, S.A., Goringe, A., Fegan, C., Davies, S.V., Giddings, J., Whittaker, J.A., et al. Parenteral glutamine protects hepatic function during bone marrow transplantation. Bone Marrow Transpl 22 (1998), 281–284.
424. Ziegler, T.R., Young, L.S., Benfell, K., Scheltinga, M., Hortos, K., Bye, R., et al. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med 116 (1992), 821–828.
425. Uderzo, C., Rebora, P., Marrocco, E., Varotto, S., Cichello, F., Bonetti, M., et al. Glutamine-enriched nutrition does not reduce mucosal morbidity or complications after stem-cell transplantation for childhood malignancies: a prospective randomized study. Transplantation 91 (2011), 1321–1325.
426. Midtgaard, J., Christensen, J.F., Tolver, A., Jones, L.W., Uth, J., Rasmussen, B., et al. Efficacy of multimodal exercise-based rehabilitation on physical activity, cardiorespiratory fitness, and patient-reported outcomes in cancer survivors: a randomized, controlled trial. Ann Oncol 24 (2013), 2267–2273.
427. Holmes, M.D., Chen, W.Y., Feskanich, D., Kroenke, C.H., Colditz, G.A., Physical activity and survival after breast cancer diagnosis. JAMA 293 (2005), 2479–2486.
428. Meyerhardt, J.A., Giovannucci, E.L., Holmes, M.D., Chan, A.T., Chan, J.A., Colditz, G.A., et al. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 24 (2006), 3527–3534.
429. Ballard-Barbash, R., Friedenreich, C.M., Courneya, K.S., Siddiqi, S.M., McTiernan, A., Alfano, C.M., Physical activity, biomarkers, and disease outcomes in Cancer survivors: a systematic review. J Natl Cancer Inst 104 (2012), 1–26.
430. Azrad, M., Demark-Wahnefried, W., The association between adiposity and breast cancer recurrence and survival: a review of the recent literature. Curr Nutr Rep 3:1 (2014), 9–15.
431. Gibson, T.M., Park, Y., Robien, K., Shiels, M.S., Black, A., Sampson, J.N., et al. Body mass index and risk of second obesity-associated cancers after colorectal cancer: a pooled analysis of prospective cohort studies. J Clin Oncol 32 (2014), 4004–4011.
432. Pekmezi, D.W., Demark-Wahnefried, W., Updated evidence in support of diet and exercise interventions in cancer survivors. Acta Oncol 50 (2011), 167–178.
433. Kim, E.H., Lee, H., Chung, H., Park, J.C., Shin, S.K., Lee, S.K., et al. Impact of metabolic syndrome on oncologic outcome after radical gastrectomy for gastric cancer. Clin Res Hepatol Gastroenterol 38 (2014), 372–378.
434. Ng, A.K., Travis, L.B., Second primary cancers: an overview. Hematol Oncol Clin North Am 22 (2008), 271–289.
435. Demark-Wahnefried, W., Rock, C.L., Patrick, K., Byers, T., Lifestyle interventions to reduce cancer risk and improve outcomes. Rev Am Fam Physician 77 (2008), 1573–1578.
436. http://www.wcrf.org/.
437. Rock, C.L., Flatt, S.W., Natarajan, L., Thomson, C.A., Bardwell, W.A., Newman, V.A., et al. Plasma carotenoids and recurrence-free survival in women with a history of breast cancer. J Clin Oncol 23 (2005), 6631–6638.
438. Chlebowski, R.T., Blackburn, G.L., Thomson, C.A., Nixon, D.W., Shapiro, A., Hoy, M.K., et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst 98 (2006), 1767–1776.
439. Pierce, J.P., Natarajan, L., Caan, B.J., Parker, B.A., Greenberg, E.R., Flatt, S.W., et al. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. JAMA 298 (2007), 289–298.
440. Pierce, J.P., Stefanick, M.L., Flatt, S.W., Natarajan, L., Sternfeld, B., Madlensky, L., et al. Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol 25 (2007), 2345–2351.
441. Wang, X., Ouyang, Y., Liu, J., Zhu, M., Zhao, G., Bao, W., et al. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ, 349, 2014, g4490 Erratum in: BMJ. 2014;349:5472.
442. Gonzalez, C.A., Riboli, E., Diet and cancer prevention: where we are, where we are going. Nutr Cancer 56 (2006), 225–231.
443. Bradbury, K.E., Appleby, P.N., Key, T.J., Fruit, vegetable, and fiber intake in relation to cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Am J Clin Nutr, 100(Suppl 1), 2014 394S–8S.
444. Farvid, M.S., Cho, E., Chen, W.Y., Eliassen, A.H., Willett WC5. Dietary protein sources in early adulthood and breast cancer incidence: prospective cohort study. BMJ, 348, 2014, g3437.
445. Sinha, R., Cross, A.J., Graubard, B.I., Leitzmann, M.F., Schatzkin, A., Meat intake and mortality: a prospective study of over half a million people. Arch Intern Med 169 (2009), 562–571.
446. Boffetta, P., Couto, E., Wichmann, J., Ferrari, P., Trichopoulos, D., Bueno-de-Mesquita, H.B., et al. Fruit and vegetable intake and overall cancer risk in the European prospective investigation into cancer and nutrition (EPIC). J Natl Cancer Inst 102 (2010), 529–537.
447. Schrijvers, D., Cherny, N.I., on behalf of the ESMO Guidelines Working Group. ESMO Clinical Practice Guidelines on palliative care: advanced care planning. Ann Oncol 25:Suppl. 3 (2014), iii138–iii142.
448. Radbruch, L., Payne, S., the Board of Directors of the EAPC, White paper on standards and norms for hospice and palliative care in Europe: Part 1. Recommendations from the European association for palliative care. Eur J Palliat Care 16 (2009), 278–289.
449. Radbruch, L., Payne, S., the Board of Directors of the EAPC, White paper on standards and norms for hospice and palliative care in Europe: Part 2. Recommendations from the European association for palliative care. Eur J Palliat Care 17 (2010), 22–33.
450. Ferris, F.D., Bruera, E., Cherny, N., Cummings, C., Currow, D., Dudgeon, D., et al. Palliative cancer care a decade later: accomplishments, the need, next steps—from the American society of clinical oncology. J Clin Oncol 27 (2009), 3052–3058.
451. World Health Organization. Definition of palliative care. http://www.who.int/cancer/palliative/definition/en/.
452. Tong, H., Isenring, E., Yates, P., The prevalence of nutrition impact symptoms and their relationship to quality of life and clinical outcomes in medical oncology patients. Support Care Cancer 17 (2009), 83–90.
453. Martin, L., Watanabe, S., Fainsinger, R., Lau, F., Ghosh, S., Quan, H., et al. Prognostic factors in patients with advanced cancer: use of the patient-generated subjective global assessment in survival prediction. J Clin Oncol 28 (2010), 4376–4383.
454. Laird, B.J., Kaasa, S., McMillan, D.C., Fallon, M.T., Hjermstad, M.J., Fayers, P., et al. Prognostic factors in patients with advanced cancer: a comparison of cliicopathological factors and the development of an inflammation-based prognostic system. Clin Cancer Res 19 (2013), 5456–5464.
455. Fearon, K.C., Cancer cachexia: developing multimodal therapy for a multidimensional problem. Eur J Cancer 44 (2008), 1124–1132.
456. Koretz, R.L., Do data support nutrition support? Part II. Enteral artificial nutrition. J Am Diet Assoc 107 (2007), 1374–1380.
457. Bozzetti, F., Effects of artificial nutrition on the nutritional status of cancer patients. J Parenter Enter Nutr 13 (1989), 406–420.
458. Amano, K., Morita, T., Baba, M., Kawasaki, M., Nakajima, S., Uemura, M., et al. Effect of nutritional support on terminally ill patients with cancer in a palliative care unit. Am J Hosp Palliat Care 30 (2013), 730–733.
459. Lundholm, K., Daneryd, P., Bosaeus, I., Körner, U., Lindholm, E., Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: effects on survival, metabolism, and founction. Cancer 100 (2004), 1967–1977.
460. Bozzetti, F., Cozzaglio, L., Biganzoli, E., Chiavenna, G., De Cicco, M., Donati, D., et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clin Nutr 21 (2002), 281–288.
461. Soo, I., Gramlich, L., Use of parenteral nutrition in patients with advanced cancer. Appl Physiol Nutr Metab 33 (2008), 102–106.
462. Cozzaglio, L., Balzola, F., Cosentino, F., DeCicco, M., Fellagara, P., Gaggiotti, G., et al. Outcome of cancer patients receiving home parenteral nutrition. Italian Society of Parenteral and Enteral Nutrition (S.I.N.P.E.). J Parenter Enter Nutr 21 (1997), 339–342.
463. Maltoni, M., Caraceni, A., Brunelli, C., Broeckaert, B., Christakis, N., Eychmueller, S., et al. Prognostic factors in advanced cancer patients: evidence-based clinical recommendations – a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol 23 (2005), 6240–6248.
464. Gripp, S., Moeller, S., Bölke, E., Schmitt, G., Matuschek, C., Asgari, S., et al. Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. J Clin Oncol 25 (2007), 3313–3320.
465. Bruera, E., Hui, D., Dalal, S., Torres-Vigil, I., Trumble, J., Roosth, J., et al. Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial. J Clin Oncol 31 (2013), 111–118.
466. Del Río, M.I., Shand, B., Bonati, P., Palma, A., Maldonado, A., Taboada, P., et al. Hydration and nutrition at the end of life: a systematic review of emotional impact, perceptions, and decisionmaking among patients, family, and health care staff. Psychooncology 21 (2012), 913–921.
467. Mallet, J., Ethical and legal aspects in nutrition. J Am Diet Assoc 108 (2008), 873–882.
468. Raijmakers, N.J., van Zuylen, L., Costantini, M., Caraceni, A., Clark, J., Lundquist, G., et al. Artificial nutrition and hydration in the last week of life in cancer patients. A systematic literature review of practices and effects. Ann Oncol 22 (2011), 1478–1486.
469. McCann, R.M., Hall, W.J., Groth-Juncker, A., Comfort care for terminally ill patients. The appropriate use of nutrition and hydration. JAMA 272 (1994), 1263–1266.
470. Good, P., Cavenagh, J., Mather, M., Ravenscroft, P., Medically assisted hydration for adult palliative care patients. Cochrane Database Syst Rev(2), 2008 Art. No.: CD006273.
471. Cerchietti, L., Navigante, A., Sauri, A., Palazzo, F., Hypodermoclysis for control of dehydration in terminal-stage cancer. Int J Palliat Nurs 6:8 (2000), 370–374.
472. Kang, J.H., Shin, S.H., Bruera, E., Comprehensive approaches to managing delirium in patients with advanced cancer. Cancer Treat Rev 39:1 (2013), 105–112.
473. Prevost, V., Grach, M.C., Nutritional support and quality of life in cancer patients undergoing palliative care. Eur J Cancer Care 21 (2012), 581–590.
474. Bozzetti, F., Home total parenteral nutrition in incurable cancer patients: a therapy, a basic humane care or something in between?. Clin Nutr 22:2 (2003), 109–111.
475. Bozzetti, F., Cotogni, P., Lo Vullo, S., Pironi, L., Giardiello, D., Mariani, L., Development and validation of a nomogram to predict survival in incurable cachectic cancer patients on home parenteral nutrition. Ann Oncol 26 (2015), 2335–2340.